rfhg_167057.1

Basic information about the TSS

---

TSS ID: rfhg_167057.1 Species: human Chr: chr14		Start: 64503262 End: 64503272 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2728612,EH38E1721141)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000556818.1:440 GeneID: 22890 HGNC/MGI_ID: HGNC:20259 UniProt_ID: Nearer transcript ids and distances: ENST00000553583.1:453

Gene_name: zinc finger and BTB domain containing 1 Gene_symbol: ZBTB1 Gene_synonyms: KIAA0997 ZNF909 Gene_source: HGNC:20259

TATA-Box annotation

---

Distance to TSS:	571
Nearest PromoterID:	NM_006977
Entrez ID:	7597
Nearest Unigene:	Hs.654571
Nearest Refseq:	NM_006977
Nearest Ensembl:	ENSG00000089775
Gene Name:	zinc finger and BTB domain containing 1
Gene Alias:	C14orf51|KUP|ZNF46
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.636364
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ZBTB1 p2@ZBTB1 p3@ZBTB1 p4@ZBTB1 p5@ZBTB1 p7@ZBTB1 p8@ZBTB1
Sample		p1@ZBTB1	p2@ZBTB1	p3@ZBTB1	p4@ZBTB1	p5@ZBTB1	p7@ZBTB1	p8@ZBTB1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	8.18	3.51	0.97	0.00	0.39	0.78	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	7.89	2.02	1.21	0.20	0.61	0.61	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	9.07	2.89	1.54	0.00	0.00	0.58	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	8.73	3.74	1.46	0.21	0.21	0.21	1.46
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	7.20	3.60	1.57	0.00	0.22	0.90	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	6.78	2.71	0.58	0.39	0.00	0.78	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	9.37	1.74	0.87	0.00	0.00	0.65	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	10.66	1.70	2.18	0.24	0.24	0.24	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	7.05	1.71	0.43	0.21	0.43	0.43	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	19.13	5.22	6.38	0.58	0.00	1.16	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	16.17	4.04	8.08	0.81	0.00	1.62	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	19.11	6.10	5.29	0.41	0.00	0.81	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	10.96	1.45	1.93	2.26	1.45	0.16	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	7.82	0.45	0.90	2.10	1.20	0.45	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.00	0.88	2.20	1.32	1.10	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	8.80	1.26	1.51	2.01	1.51	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	8.95	1.09	1.75	1.53	2.84	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	11.39	0.42	1.27	1.27	1.27	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	10.13	1.60	2.13	3.20	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	12.64	1.20	1.81	2.41	1.35	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.30	1.47	1.34	1.60	2.14	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.70	1.21	2.24	2.76	0.86	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	11.76	2.71	1.42	3.10	0.52	0.52	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	14.32	1.70	1.46	2.43	0.49	0.97	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	11.61	1.29	1.55	3.61	1.81	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	12.98	0.95	0.63	2.53	0.95	1.27	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	14.29	1.65	2.75	3.30	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	15.09	6.60	0.94	2.12	0.94	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	12.92	2.91	1.45	3.23	0.16	0.65	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	13.39	3.80	1.63	2.71	0.72	1.27	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	13.40	2.51	0.63	1.88	1.26	1.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	12.50	3.52	1.37	0.98	1.37	0.59	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	12.45	1.90	0.84	1.27	0.63	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	11.55	0.33	0.66	2.14	0.33	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	10.10	2.24	0.75	2.06	1.12	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	13.99	2.68	0.77	3.64	1.72	2.11	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	11.04	1.64	0.61	1.84	0.82	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.87	2.01	1.21	1.21	0.40	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	10.26	1.35	0.00	1.89	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.40	1.92	0.72	0.72	0.72	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	10.59	0.71	0.94	1.88	1.41	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.66	0.44	0.59	0.88	1.02	0.29	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	12.23	2.11	0.84	1.48	0.63	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	14.69	1.75	0.52	0.52	1.57	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	11.24	1.20	1.61	0.40	2.01	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	16.52	1.86	0.70	1.86	1.63	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	17.27	2.16	0.72	1.92	1.44	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	14.90	1.79	0.89	1.19	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	17.95	3.11	0.72	1.44	0.24	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	14.36	1.42	0.61	0.81	1.01	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	18.65	1.43	1.23	0.41	1.64	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	19.79	2.00	2.00	2.45	1.33	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	19.87	3.55	1.42	1.06	1.77	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	17.89	3.31	1.33	0.66	0.00	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	13.42	1.68	0.00	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	15.15	1.38	0.46	1.84	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	19.45	4.54	0.32	0.97	1.94	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	20.88	1.61	0.96	0.32	0.96	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	11.00	1.89	0.63	1.57	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	28.91	3.53	0.00	1.41	2.82	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	26.36	2.24	0.00	1.68	2.24	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	8.76	0.80	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	18.01	0.34	0.34	1.36	0.00	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	20.47	1.95	1.30	1.62	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	20.23	3.55	0.00	0.71	0.71	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	17.55	2.93	0.98	1.46	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	16.36	0.50	0.00	0.50	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	16.42	3.75	0.94	1.88	0.00	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	9.60	0.99	3.97	1.32	0.00	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	14.54	2.17	1.24	0.93	0.62	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	17.73	1.83	1.83	1.22	0.61	0.31	0.61
Adipocyte - breast, donor1	11376-118A8	51.16	5.86	1.27	2.38	0.32	2.53	0.79
Adipocyte - breast, donor2	11327-117E4	37.22	4.49	0.16	1.44	0.16	0.96	0.64
Adipocyte - omental, donor1	11473-119C6	47.46	4.07	0.38	1.27	0.13	1.40	0.25
Adipocyte - omental, donor2	11474-119C7	32.14	0.75	0.00	0.75	0.00	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	23.44	1.34	1.34	0.33	0.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	28.07	0.00	1.28	0.00	1.28	0.64	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	2.20	0.00	4.40	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	9.94	0.45	0.45	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	7.47	0.35	0.17	0.35	0.35	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	20.93	2.15	0.98	0.00	1.37	0.39	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	23.94	1.80	1.80	0.77	0.26	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	17.56	1.67	0.56	0.56	1.67	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	17.05	1.18	1.76	0.00	1.76	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	25.66	2.65	0.80	0.40	0.24	0.24	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	21.30	1.94	1.61	0.32	0.97	1.94	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	12.26	2.13	0.53	0.53	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	20.59	0.56	1.67	0.00	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	13.72	0.42	1.25	0.42	0.83	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	17.83	1.26	0.50	0.50	0.75	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	13.42	1.64	0.65	0.33	0.33	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	13.09	0.61	1.52	0.00	0.91	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	7.07	0.00	0.00	0.44	0.00	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	2.51	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	13.13	0.54	0.18	1.08	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	0.00	0.00	1.67	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	6.99	0.62	1.03	0.41	0.41	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	20.60	1.37	0.46	1.37	0.46	0.57	0.23
Anulus Pulposus Cell, donor2	11463-119B5	14.69	0.49	0.24	0.98	0.73	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	10.33	0.45	0.00	0.90	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	19.54	0.87	0.00	0.87	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	16.74	0.60	0.30	0.60	0.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	18.97	0.00	0.00	0.00	0.00	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	10.56	1.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	15.92	0.97	0.65	0.00	0.00	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	12.14	1.94	0.97	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	15.44	2.97	0.00	1.19	0.59	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	14.31	0.00	0.38	0.38	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	14.51	0.00	0.00	1.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	17.55	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	21.25	0.82	0.16	0.49	0.99	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	0.00	0.00	1.36	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	19.00	0.60	0.30	0.30	0.60	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	17.68	1.07	0.00	0.54	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	16.82	1.13	0.19	0.38	0.57	0.38	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	14.70	0.53	0.27	0.80	0.27	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	8.78	0.00	0.00	0.00	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	12.61	0.50	0.17	0.50	0.17	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	0.00	0.00	3.54	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.38	1.03	0.00	0.86	0.86	0.34	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	19.42	0.49	0.00	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	14.42	0.76	0.00	0.76	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	15.75	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	13.11	0.57	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	17.53	0.64	0.43	0.64	0.64	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	14.45	0.00	0.52	0.26	0.26	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	13.61	0.47	0.00	1.88	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	18.01	1.29	0.00	0.00	0.00	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	17.84	1.43	0.00	1.43	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	16.96	0.00	0.00	0.00	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	18.06	0.30	0.30	0.90	0.00	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	11.88	0.00	0.00	2.38	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	13.73	1.02	0.00	0.51	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	15.79	0.00	0.25	0.51	0.00	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	14.61	1.27	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	11.22	0.00	0.43	0.86	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	13.55	0.64	0.21	0.42	0.00	0.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.60	0.00	0.29	0.58	0.29	0.58	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	14.17	0.00	0.00	1.89	0.00	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	11.36	0.34	0.34	0.85	0.34	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	8.45	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	15.44	0.43	0.21	1.07	0.21	0.43	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	16.85	1.20	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	10.93	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	13.79	0.00	0.00	0.23	0.69	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	21.36	0.76	0.76	0.25	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	15.48	1.24	0.00	0.62	0.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	22.34	1.22	0.31	0.31	0.92	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	15.77	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	14.41	0.22	0.22	0.67	0.22	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	15.26	1.53	0.00	0.00	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	17.17	0.00	0.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	17.21	0.53	0.00	0.26	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	11.99	0.36	0.36	0.36	0.00	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	8.35	0.00	0.25	0.12	0.12	0.25	0.12
Astrocyte - cerebellum, donor2	11580-120F5	8.04	0.00	0.17	0.17	0.51	0.00	1.03
Astrocyte - cerebellum, donor3	11661-122F5	3.36	0.00	0.00	0.21	0.21	0.00	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	20.57	1.05	1.05	0.35	1.74	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	23.78	1.29	1.13	0.65	1.94	0.32	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	21.48	3.58	0.89	0.89	1.19	0.30	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	21.90	5.28	0.23	1.61	0.34	1.38	1.83
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	24.93	3.63	0.13	0.25	0.38	0.75	1.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	26.29	4.21	0.57	0.23	0.11	1.59	1.25
Basophils, donor1	12241-129G9	54.66	3.66	2.62	0.26	0.00	1.83	0.00
Basophils, donor2	12242-129H1	312.81	18.76	0.72	2.53	0.00	3.97	0.00
Basophils, donor3	12243-129H2	112.01	11.47	1.32	1.18	0.44	2.65	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	2.16	0.43	0.22	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	6.86	0.46	1.37	0.91	0.00	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	10.04	0.00	0.63	0.63	0.63	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	6.03	0.42	0.42	0.83	0.00	0.62	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	7.14	0.00	1.15	0.69	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	14.76	0.90	1.98	0.36	0.00	0.90	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	22.16	1.44	0.82	0.31	1.75	0.31	1.34
Burkitt's lymphoma cell line:RAJI	10476-106I8	27.02	2.56	0.47	0.00	0.93	0.23	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	55.00	3.52	2.56	0.32	0.00	0.64	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	144.79	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	66.50	5.64	7.33	0.56	0.00	1.69	0.56
CD14+ Monocytes, donor2	11305-117B9	104.86	8.72	3.90	0.74	0.56	2.78	0.19
CD14+ Monocytes, donor3	11381-118B4	96.60	9.22	4.61	0.88	0.44	1.98	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	44.44	1.98	3.11	0.28	1.42	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	52.31	2.65	3.79	0.38	0.00	0.76	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	56.21	1.97	2.96	1.31	1.97	1.97	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	59.55	2.60	1.16	4.77	0.29	0.29	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	57.93	3.02	1.51	10.56	0.00	0.91	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	72.96	2.84	0.24	8.29	0.47	0.47	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	52.56	3.01	1.17	6.19	0.00	0.84	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	67.35	6.07	0.28	13.52	0.00	1.66	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	76.61	7.19	0.74	15.37	0.00	0.50	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	30.54	0.98	0.78	5.29	0.59	1.17	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	43.62	2.49	0.53	6.05	0.36	0.36	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	47.66	3.48	0.44	6.96	0.22	0.87	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	29.50	4.21	1.17	3.75	0.00	1.40	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	73.40	4.75	1.06	10.03	0.00	1.58	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	82.09	4.44	0.00	7.77	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	73.33	3.27	0.74	9.22	0.15	1.93	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	75.23	4.99	0.40	14.17	0.00	1.80	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	85.57	5.41	1.46	15.82	0.00	1.25	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	41.18	2.75	0.46	8.92	0.23	0.92	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	68.09	3.39	0.00	16.06	0.00	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	59.80	5.67	0.44	12.66	0.00	2.18	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	31.20	1.34	0.27	1.88	0.00	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	36.46	1.05	0.52	4.71	0.17	0.70	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	43.34	0.42	0.84	4.21	0.00	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	20.76	1.29	0.55	2.20	0.37	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	32.41	2.82	0.35	3.17	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	34.22	0.88	1.75	6.58	0.88	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	33.65	3.31	0.70	6.10	0.17	0.70	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	50.92	3.35	1.12	11.52	0.00	1.49	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	55.61	3.45	1.08	9.27	0.22	1.72	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	18.84	0.41	0.82	1.23	0.00	0.41	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	40.10	3.25	0.70	4.40	0.00	1.16	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	34.10	2.78	1.16	3.71	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	79.12	3.92	2.83	0.65	0.00	1.31	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	86.16	3.93	2.77	2.31	0.23	0.92	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	60.65	2.60	4.55	0.65	0.22	0.43	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	79.42	5.14	2.34	0.78	0.00	1.25	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	64.97	3.49	3.49	0.70	0.17	1.22	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	74.47	3.57	3.34	0.22	0.00	0.45	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	69.15	2.30	6.63	1.28	0.26	0.51	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	73.33	3.29	3.73	0.44	0.22	0.88	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	64.22	3.79	4.84	0.21	0.42	0.84	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	56.90	4.06	4.06	0.00	2.03	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	52.88	2.71	2.71	0.00	0.00	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	45.57	9.32	5.18	0.00	0.00	1.04	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	53.84	3.73	2.13	1.07	0.00	2.13	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	62.18	2.14	3.75	1.07	0.54	2.14	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	48.43	2.81	1.40	0.70	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	58.83	0.00	0.78	0.00	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	63.28	1.32	5.27	0.00	0.00	1.32	2.64
CD19+ B Cells, donor1	11544-120B5	239.99	24.66	5.75	2.47	0.00	4.93	0.00
CD19+ B Cells, donor2	11624-122B4	282.92	17.41	1.45	0.00	0.00	6.53	0.00
CD19+ B Cells, donor3	11705-123B4	231.21	22.72	2.02	0.50	0.00	8.08	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	14.14	2.02	1.62	0.00	0.40	0.00	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	10.79	0.40	2.40	1.20	0.40	0.40	0.80
CD34+ Progenitors, donor1	11545-120B6	127.51	6.02	0.00	1.00	0.00	3.01	0.00
CD34+ Progenitors, donor2	11625-122B5	114.61	5.62	0.56	2.25	0.00	1.69	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	37.58	1.88	3.01	0.38	0.00	1.13	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	40.81	2.93	2.71	0.00	0.23	0.68	0.23
CD4+ T Cells, donor1	11225-116C1	280.29	15.00	2.14	0.36	0.36	5.00	1.07
CD4+ T Cells, donor2	11306-117C1	285.97	12.25	3.67	0.61	0.00	4.29	0.00
CD4+ T Cells, donor3	11382-118B5	321.16	23.79	2.44	0.30	0.00	4.27	1.52
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	75.81	1.79	2.81	0.26	0.00	0.26	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	77.49	1.57	2.70	0.22	0.22	1.12	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	89.69	2.59	1.44	0.57	1.15	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	199.59	12.80	5.22	0.00	0.47	2.37	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	125.01	7.02	10.53	0.00	0.00	2.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	131.85	9.89	13.18	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	58.67	1.59	0.58	0.72	0.00	0.43	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	50.84	2.20	1.53	0.17	0.34	0.51	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	55.29	3.55	1.45	0.32	0.48	0.97	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	186.04	6.72	2.24	0.90	0.00	6.28	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	136.26	6.29	5.24	0.00	0.00	3.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	132.87	5.28	5.72	0.00	0.00	3.52	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	79.69	0.42	0.42	0.84	0.00	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	56.51	1.66	1.45	0.21	0.62	0.83	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	75.18	3.68	2.00	0.00	0.67	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	139.77	6.53	5.44	0.00	0.54	1.36	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	133.99	6.97	16.61	0.00	0.00	2.68	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	120.15	10.76	8.97	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	56.18	1.67	0.37	0.37	0.19	0.93	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	47.66	0.65	0.87	0.00	0.00	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	60.31	3.36	1.47	0.00	0.21	0.63	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	145.11	5.56	7.08	0.00	0.00	3.03	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	117.41	9.53	9.96	0.43	0.00	2.60	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	132.92	8.28	2.61	0.44	0.00	1.74	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	83.63	2.97	3.96	0.00	0.49	0.99	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	78.47	2.77	1.85	0.00	0.00	0.92	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	76.77	0.00	9.77	0.00	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	95.82	1.38	3.05	0.55	0.00	1.38	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	97.17	1.47	4.17	0.00	0.49	0.49	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	110.88	1.54	6.16	0.00	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	83.08	3.58	4.66	1.43	0.00	0.36	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	102.49	4.15	4.15	1.38	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	369.30	35.69	1.64	0.33	0.00	8.51	0.65
CD8+ T Cells, donor2	11307-117C2	369.43	29.28	1.50	0.38	0.38	7.88	0.00
CD8+ T Cells, donor3	11383-118B6	329.25	31.31	1.77	0.76	0.25	6.31	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	20.65	2.29	0.00	0.00	0.00	0.69	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	15.10	0.96	0.24	0.48	0.00	0.96	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	16.96	2.74	0.27	0.55	0.00	0.82	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	17.11	2.70	0.00	0.60	0.00	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	15.84	3.36	0.00	0.00	0.00	2.16	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	20.24	0.91	0.45	0.68	0.00	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	23.90	3.48	0.87	0.87	0.00	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	23.69	2.37	0.79	0.53	0.00	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	23.45	2.58	0.23	0.47	0.00	1.17	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	21.13	3.32	0.91	0.60	0.30	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	20.04	2.32	0.29	0.29	0.00	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	22.65	5.33	0.53	0.27	0.00	1.33	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	32.39	11.82	0.00	3.50	0.00	1.31	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	30.51	6.38	0.46	1.82	0.00	2.28	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	31.33	6.71	0.00	2.98	0.00	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	21.97	4.68	0.72	0.36	0.00	2.16	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	18.41	4.60	0.58	1.44	0.00	0.58	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	16.03	5.19	0.24	0.47	0.00	0.94	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	21.87	4.44	0.63	1.27	0.32	0.95	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	26.76	4.00	0.00	0.62	0.00	1.54	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	16.67	3.85	0.64	0.64	0.00	1.60	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	13.00	2.68	0.38	0.76	0.00	1.91	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.89	1.58	0.00	0.39	0.00	1.97	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	20.42	2.27	1.51	0.76	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	51.39	16.06	1.61	4.01	0.00	5.62	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	48.96	18.19	2.10	2.80	0.00	3.50	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	61.11	19.03	4.01	5.01	0.00	7.01	0.00
Cardiac Myocyte, donor1	11525-119I4	82.25	3.66	1.83	5.48	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	18.28	0.00	0.99	0.00	0.99	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	18.73	1.47	0.21	0.95	0.42	0.32	0.42
Chondrocyte - de diff, donor1	11261-116G1	15.95	0.35	0.35	2.43	0.00	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	7.11	1.42	0.71	1.07	0.36	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	14.68	1.14	1.14	2.16	0.91	0.11	0.23
Chondrocyte - re diff, donor2	11339-117F7	18.80	0.90	0.90	1.79	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	10.51	0.40	0.00	5.66	0.81	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	33.28	2.64	1.49	0.23	2.18	1.26	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	22.87	3.21	0.86	0.43	0.43	0.64	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	29.74	3.10	0.71	0.35	1.24	0.97	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	10.00	0.73	1.10	0.83	1.74	0.18	0.46
Corneal Epithelial Cells, donor1	11526-119I5	1.76	0.00	0.66	0.00	0.22	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	3.41	0.00	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	4.09	0.00	0.51	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	70.00	4.95	1.82	0.66	0.33	0.99	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	65.61	5.36	1.26	0.32	0.00	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	44.86	6.90	0.00	3.45	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	51.08	9.29	1.62	0.22	0.11	1.19	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	248.03	26.65	1.02	0.68	0.00	8.88	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	246.13	16.97	3.26	1.31	0.65	3.92	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	251.17	8.71	2.90	0.48	0.97	5.81	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	8.51	0.33	0.00	0.50	0.50	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	5.87	0.59	0.00	0.00	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	9.62	0.00	0.57	0.85	0.28	0.28	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	11.01	0.00	0.39	0.79	0.79	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	6.40	0.58	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	12.00	0.24	0.24	0.71	0.47	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	6.66	0.35	0.35	0.35	0.18	0.00	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	24.83	0.89	0.66	1.99	1.11	0.44	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	26.17	1.52	0.61	0.91	0.30	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	37.49	1.41	0.28	1.41	0.00	0.28	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	14.86	0.00	0.00	0.59	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	8.85	0.00	0.00	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	11.91	0.43	0.28	0.28	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	22.41	0.00	0.40	0.00	0.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	10.48	0.52	1.05	0.00	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	32.18	0.62	0.37	1.86	1.12	0.50	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	17.38	0.43	0.43	1.09	0.43	0.22	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	16.85	1.22	0.37	0.85	0.37	0.12	0.24
Endothelial Cells - Vein, donor1	11267-116G7	9.10	0.00	1.14	1.14	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	6.99	0.70	0.00	0.70	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	12.09	1.10	0.16	0.31	0.31	0.47	0.31
Eosinophils, donor1	12244-129H3	396.42	15.25	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	348.21	19.80	11.55	4.95	0.00	1.65	0.00
Eosinophils, donor3	12246-129H5	310.31	17.83	10.70	0.00	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	3.42	0.00	0.98	0.49	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	17.24	2.05	0.41	0.82	0.41	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	6.02	0.11	0.22	0.55	0.11	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	6.39	0.43	0.11	1.52	0.33	0.22	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	12.37	1.33	0.24	1.70	0.49	0.49	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	32.07	1.91	1.09	1.36	0.68	0.55	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	10.13	0.84	0.32	0.84	0.95	0.21	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	18.97	0.26	2.37	2.63	1.05	0.53	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	14.28	1.99	1.00	1.00	0.33	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	11.34	0.45	0.45	0.45	0.45	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	8.34	0.00	0.00	0.76	0.00	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	5.20	0.79	0.32	0.16	0.00	0.32	0.16
Fibroblast - Cardiac, donor4	11452-119A3	29.40	3.03	1.21	0.91	0.61	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	20.05	0.51	1.02	1.78	0.63	0.38	0.25
Fibroblast - Cardiac, donor6	11460-119B2	21.07	0.76	0.76	1.67	0.45	0.15	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	12.86	0.54	0.40	0.13	0.40	1.21	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	19.85	1.73	0.00	0.43	0.00	1.73	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	14.65	0.00	0.00	0.00	0.00	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	1.85	0.23	0.23	0.23	0.00	0.23	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	17.13	1.53	0.68	0.85	0.68	0.51	0.17
Fibroblast - Dermal, donor1	11269-116G9	14.56	0.94	0.23	0.23	0.23	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	10.85	0.94	0.47	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	15.23	1.33	0.24	0.85	0.36	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	12.21	0.45	0.45	0.57	0.57	0.45	0.45
Fibroblast - Dermal, donor5	11454-119A5	17.97	0.52	0.52	1.05	0.52	0.17	0.35
Fibroblast - Dermal, donor6	11458-119A9	22.09	0.49	0.49	1.30	0.32	0.32	0.32
Fibroblast - Gingival, donor1	11237-116D4	18.53	1.25	1.67	1.46	1.04	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	21.22	1.57	0.26	1.31	0.26	0.79	0.26
Fibroblast - Gingival, donor2	11318-117D4	14.76	1.19	0.40	1.71	1.05	0.13	0.00
Fibroblast - Gingival, donor3	11394-118C8	15.76	1.45	0.77	0.87	0.68	0.39	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	10.39	2.08	1.04	0.00	2.08	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	14.10	0.88	0.88	0.53	0.53	0.35	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	15.75	1.40	0.31	0.78	0.94	0.16	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	15.15	0.68	0.54	1.08	0.68	0.54	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	9.88	3.18	0.71	0.35	0.00	0.71	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	21.06	0.44	1.75	1.02	0.29	0.44	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	18.41	1.09	0.55	0.95	0.41	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	17.33	1.43	0.77	0.66	0.66	0.22	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	19.22	1.76	1.47	0.88	1.17	0.00	0.73
Fibroblast - Lung, donor1	11270-116H1	10.87	0.00	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	25.37	1.49	0.00	0.00	1.49	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	11.82	1.69	0.21	1.69	0.21	0.63	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	6.66	0.00	0.00	0.00	0.83	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	6.99	0.00	2.80	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.68	0.28	0.56	0.00	0.28	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	8.53	0.00	0.81	0.41	0.00	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	11.91	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	17.85	0.78	1.36	2.72	0.39	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	17.90	0.91	0.30	3.64	1.21	0.15	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	22.34	1.22	0.61	0.92	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	15.65	1.14	1.53	1.14	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	14.04	1.35	0.27	0.81	1.08	0.27	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	12.29	2.09	1.04	0.81	0.58	0.23	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	15.25	1.22	0.22	1.33	0.11	0.22	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	8.94	0.81	0.41	1.02	0.00	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	7.35	0.67	0.67	0.00	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	11.07	0.79	1.19	0.40	0.40	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	40.88	1.39	1.39	3.97	0.60	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	31.26	1.42	1.60	0.89	0.89	0.18	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	32.52	1.38	0.99	0.99	0.39	0.99	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	35.50	1.50	2.41	2.71	0.00	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	25.58	0.76	0.54	1.19	0.65	1.08	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	46.82	3.29	4.56	2.53	0.00	0.51	0.51
Fibroblast - skin normal, donor1	11553-120C5	22.15	1.64	0.82	1.15	0.00	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	42.71	6.42	0.80	5.41	0.80	0.20	0.80
Fibroblast - skin normal, donor2	11561-120D4	30.94	1.00	0.60	2.41	0.50	0.60	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	52.89	1.51	3.63	4.23	1.21	1.21	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	26.84	1.33	1.33	1.16	0.58	0.58	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	24.79	0.51	1.20	2.39	0.68	0.85	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	42.37	3.28	3.61	3.28	0.33	0.33	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	25.35	0.32	0.43	1.38	0.64	0.53	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	14.68	1.18	0.51	1.69	0.17	0.51	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	13.80	1.41	0.31	0.94	0.00	0.16	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.89	3.49	7.84	2.61	0.87	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	31.20	2.08	0.17	1.04	0.35	1.04	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	36.95	2.08	0.52	0.52	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	25.81	1.28	0.26	2.04	0.51	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	16.08	4.59	3.06	0.00	1.53	2.30	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	26.16	1.91	0.00	0.00	2.55	1.28	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	14.26	3.14	2.28	0.00	2.00	0.57	4.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	13.51	2.21	2.76	0.00	3.86	2.21	7.17
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	15.30	3.42	3.20	0.23	1.83	1.14	7.76
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	15.45	1.78	2.58	0.20	2.77	1.19	4.16
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	12.16	3.17	2.38	0.26	3.97	0.79	10.84
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	13.37	1.63	2.28	0.33	1.96	1.30	9.13
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	13.71	1.77	3.54	0.44	3.10	0.00	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	10.32	1.41	3.67	0.00	2.40	0.42	4.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	10.10	0.74	3.82	0.37	1.11	0.49	1.97
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	11.28	1.07	1.88	0.27	1.07	0.54	2.95
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	17.47	0.74	1.24	1.12	0.99	0.74	1.24
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	14.26	0.69	1.94	0.83	1.11	0.97	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	14.84	1.02	1.42	0.61	1.63	0.41	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	16.89	0.46	1.37	0.68	1.14	0.68	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	16.07	0.87	2.24	1.37	0.37	0.25	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	10.27	1.53	2.62	0.22	0.87	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	13.00	0.89	1.77	0.59	0.89	0.30	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	16.37	1.11	2.54	0.64	1.11	0.32	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	11.84	0.22	1.79	0.22	0.89	0.22	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	21.37	1.01	1.81	1.21	2.82	0.60	2.82
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	17.98	1.70	1.70	1.02	2.04	0.34	1.19
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	26.78	1.15	2.22	0.89	1.77	0.35	1.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	22.89	1.46	1.66	0.31	1.87	0.83	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	24.59	0.85	0.85	0.17	1.02	0.00	1.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	22.35	1.00	1.22	0.55	0.89	0.22	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	25.46	1.50	2.41	0.75	1.41	0.58	2.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.76	1.63	2.04	1.23	1.63	0.20	2.45
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	18.36	1.24	1.65	0.41	1.65	0.62	1.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	21.10	1.27	2.31	0.92	3.00	0.69	2.08
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	14.84	1.00	1.17	0.33	1.00	0.83	1.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	16.09	1.32	1.98	0.22	1.54	1.32	1.54
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	22.02	0.49	2.71	0.61	1.35	0.49	1.48
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	15.56	1.30	0.81	0.49	1.30	0.00	1.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	18.60	0.64	2.57	0.64	1.60	0.00	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	18.29	0.57	1.04	1.04	2.27	0.57	1.52
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	15.82	1.11	1.11	1.27	1.27	0.32	2.53
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	16.42	0.61	0.61	0.61	1.22	0.61	2.13
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	22.37	1.88	0.31	0.63	1.78	0.52	0.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	16.47	0.22	1.54	0.44	1.54	0.00	1.98
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	18.80	0.84	0.56	0.56	1.96	0.56	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	25.18	1.57	0.74	0.65	1.11	0.65	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	22.73	0.53	1.34	0.00	1.07	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	23.41	1.22	0.31	0.77	1.22	0.31	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	18.65	0.91	0.91	0.26	0.91	0.52	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	15.72	1.63	1.90	0.00	1.63	0.81	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	33.37	2.03	1.29	0.74	1.29	0.74	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	23.91	1.97	0.88	0.44	2.19	1.10	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	34.71	1.98	2.98	0.00	0.00	2.98	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	24.54	1.45	1.32	1.45	0.40	0.26	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	25.62	2.62	1.41	1.21	1.21	0.81	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	29.48	2.54	0.51	0.51	1.02	0.76	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	15.53	0.20	4.38	0.00	1.19	0.40	2.79
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	13.25	0.62	2.77	0.15	2.16	0.46	2.16
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	13.50	0.61	6.14	0.41	2.25	0.61	3.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	9.70	0.94	1.56	0.00	1.25	0.00	1.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	7.35	0.28	1.98	0.28	0.57	0.57	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	7.38	0.00	3.69	0.00	3.23	0.00	5.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	7.42	4.95	0.00	0.00	2.47	4.95	12.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	13.54	2.71	3.48	0.00	1.16	1.55	3.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	12.84	1.60	1.60	0.00	1.60	0.00	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	15.65	1.74	0.00	0.00	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	13.34	1.95	1.95	0.00	0.98	0.98	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	14.82	1.24	2.88	0.82	2.47	1.24	3.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	29.99	3.33	6.66	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	12.02	0.56	2.24	0.00	1.68	1.68	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	17.00	0.98	0.65	0.33	0.65	0.65	3.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	16.78	1.68	3.36	0.00	1.68	0.00	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	16.86	2.23	0.95	0.95	1.59	0.32	4.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	14.27	1.36	0.34	0.00	1.36	0.34	4.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	27.15	2.09	6.26	0.00	6.26	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	11.45	1.15	0.57	0.00	1.72	0.00	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	8.29	1.18	2.07	1.48	1.18	0.30	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	18.64	3.39	5.08	0.00	1.69	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	16.15	2.07	0.00	0.00	1.66	0.41	3.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	16.80	1.15	0.92	0.00	0.92	0.69	3.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	5.27	0.00	0.00	0.00	0.00	21.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	15.76	1.92	1.54	0.77	1.54	1.54	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	12.39	1.96	1.96	0.65	0.65	0.98	2.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	9.36	1.34	2.68	0.67	2.01	0.00	5.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	11.94	1.54	3.85	0.00	1.93	0.77	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	37.32	3.08	0.68	1.37	1.37	2.05	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	17.39	7.45	19.88	0.00	2.48	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	11.80	1.42	4.72	0.00	1.42	0.47	3.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	7.85	0.60	5.43	0.00	3.62	0.00	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	15.26	2.54	4.58	2.03	2.03	2.03	3.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	13.56	1.99	2.39	1.20	2.79	0.40	2.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	16.77	0.49	5.43	0.99	5.92	1.48	5.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	20.07	1.18	11.80	1.18	0.00	0.00	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	10.50	0.58	4.67	0.58	2.92	0.00	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	8.78	2.63	5.71	1.32	3.51	1.32	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	16.11	5.09	1.70	0.85	5.93	1.70	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	13.73	1.19	1.19	0.00	1.79	1.19	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	17.95	0.49	0.49	0.00	0.97	1.94	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	10.27	1.14	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.06	0.83	1.25	0.42	0.42	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	13.49	2.25	0.00	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	26.32	0.95	2.22	0.00	0.00	0.95	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.87	0.84	0.42	0.00	0.84	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	11.72	0.93	0.35	0.35	0.35	0.23	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	14.69	0.51	0.00	0.34	1.86	0.17	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	12.06	0.91	0.91	0.91	0.23	0.46	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	10.28	0.98	0.44	0.77	0.44	0.87	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	12.25	2.36	0.64	0.43	0.21	0.86	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	12.06	1.08	0.43	1.51	0.22	0.65	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	4.48	0.50	0.37	0.87	0.75	0.12	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	5.83	1.20	0.17	0.17	0.34	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	7.37	0.32	0.32	0.32	0.64	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	15.11	0.00	0.00	0.56	0.00	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.03	0.00	0.00	0.87	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	0.00	0.00	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	7.76	0.00	0.71	0.00	0.00	0.35	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.81	0.00	0.73	0.00	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	9.27	0.52	0.17	0.35	0.17	0.00	0.35
Hepatocyte, donor1	11523-119I2	14.53	0.00	3.63	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	14.01	0.00	1.08	0.00	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	10.43	0.00	1.23	0.00	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	52.21	1.96	1.31	0.00	0.00	1.31	7.18
Intestinal epithelial cells (polarized), donor1	11246-116E4	18.70	2.80	3.67	0.70	0.35	0.52	1.40
Iris Pigment Epithelial Cells, donor1	11530-119I9	15.50	1.51	0.41	0.41	0.69	0.55	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	0.00	0.00	0.00	0.00	0.00	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	2.50	0.00	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	0.00	0.00	0.00	0.00	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	1.62	3.25	0.00	1.62	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	1.32	1.32	1.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	3.15	0.00	1.26	0.00	0.00	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	1.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	2.58	0.65	1.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	0.00	0.00	0.00	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.00	0.00	0.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	1.26	0.42	0.00	0.00	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	1.61	0.00	1.61	0.80	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	1.85	0.00	0.00	0.00	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	2.36	0.47	0.47	0.00	0.00	0.00	1.89
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	0.00	0.91	0.00	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	1.08	0.00	0.00	0.00	0.00	0.00	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1.27	0.00	0.00	0.00	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.00	0.64	0.00	0.00	0.00	0.00	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	1.82	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	1.43	0.71	0.71	0.00	0.00	0.00	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.93	0.00	1.54	0.00	0.31	0.00	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	0.00	0.00	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.00	0.00	1.39	0.00	0.70	0.00	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.00	0.00	0.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	0.00	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	3.48	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	0.00	0.00	2.13	0.00	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.92	0.00	0.92	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	3.03	0.00	0.00	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1.06	0.00	2.11	0.00	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	23.99	1.22	0.82	1.71	0.49	0.41	0.16
Keratinocyte - epidermal, donor2	11349-117G8	1.76	0.00	0.59	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	14.67	0.85	0.38	1.04	0.28	0.19	0.00
Keratinocyte - oral, donor1	11251-116E9	30.65	2.16	2.04	1.36	0.45	0.34	0.00
Keratocytes, donor1	11527-119I6	3.44	0.00	0.34	0.69	0.34	0.00	0.34
Keratocytes, donor2	11607-120I5	3.52	0.00	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	11.26	1.38	0.59	1.38	0.00	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	21.98	0.00	2.20	4.40	0.00	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	14.02	0.00	1.08	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	23.87	0.12	0.23	0.35	0.92	0.23	0.46
Lens Epithelial Cells, donor3	11690-122I7	21.70	1.41	0.30	0.10	0.30	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	13.04	0.24	0.12	0.59	0.12	0.12	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.14	0.28	0.00	0.28	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	22.67	0.31	0.00	1.10	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	9.14	0.54	1.08	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.67	0.32	0.32	0.00	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.25	0.00	0.22	0.65	0.11	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	14.36	0.00	0.00	1.23	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	2.28	0.00	0.00	0.51	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	10.42	0.14	0.14	0.42	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	13.05	0.79	0.00	1.19	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.50	0.00	0.19	0.97	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.55	0.19	0.00	0.19	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	7.67	0.00	0.00	1.05	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	4.77	0.00	0.00	1.19	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.32	0.00	0.00	0.27	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	15.40	0.62	0.62	1.23	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.36	0.00	0.62	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.42	0.18	0.00	0.18	0.00	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	8.56	0.66	0.66	0.66	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	3.81	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	6.22	0.00	0.00	0.25	0.25	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	11.64	0.00	0.00	1.45	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	11.85	0.00	0.00	1.08	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.87	0.00	0.15	0.61	0.15	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	6.22	0.52	0.52	0.00	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	12.14	0.21	0.21	0.42	0.00	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	5.56	0.00	0.00	0.45	0.30	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	15.82	0.00	0.69	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	7.34	0.75	0.19	0.94	0.19	0.00	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	6.15	0.32	0.32	0.21	0.21	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	18.41	0.00	0.00	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	6.95	0.33	0.33	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	6.57	0.12	0.00	0.12	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	19.99	1.48	0.37	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	5.68	0.25	0.00	0.74	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	3.99	0.14	0.00	0.55	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	14.47	0.96	0.32	1.29	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	14.61	0.30	0.91	1.22	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	15.12	0.14	0.28	0.56	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	15.64	0.00	1.07	0.71	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4.36	0.00	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.73	0.31	0.00	0.31	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	13.61	0.00	0.36	1.07	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	6.86	0.33	0.00	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.47	0.24	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	16.58	0.25	0.37	0.87	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.38	0.51	0.26	0.51	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	7.16	0.00	0.00	0.00	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	2.27	0.00	2.27	0.00	0.00	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	32.99	7.67	1.53	0.00	0.00	0.00	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	16.33	2.23	2.23	0.00	0.00	0.74	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	32.58	2.54	0.85	0.42	0.42	0.42	2.54
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	17.58	0.70	0.70	0.70	0.70	0.00	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	19.61	0.93	0.93	0.93	0.93	0.93	5.60
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	23.19	3.61	0.52	0.52	1.03	0.52	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	24.98	3.57	2.38	0.00	0.00	0.00	4.76
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	26.46	3.62	2.04	1.36	0.45	0.68	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	34.61	2.04	1.74	1.45	1.16	0.58	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	36.91	2.70	0.90	1.35	0.90	0.45	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	37.53	2.03	2.30	0.41	1.08	0.68	1.63
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	41.08	2.57	0.51	0.51	1.54	1.03	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	38.11	3.18	0.35	1.41	0.71	0.71	2.82
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	32.65	1.33	0.67	1.33	0.67	2.00	3.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	46.86	3.06	2.04	0.00	1.02	2.04	5.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	38.95	2.67	1.33	0.53	0.53	0.53	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	33.25	3.78	1.32	1.13	1.32	0.94	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	46.63	5.52	2.45	1.23	1.84	0.00	4.91
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	41.59	0.00	2.45	2.45	0.00	1.63	4.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	40.40	3.75	0.62	1.25	0.62	0.83	1.87
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	51.01	4.20	0.84	0.56	0.28	1.40	2.52
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	39.15	3.09	3.09	1.03	1.03	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	47.32	5.81	0.29	1.16	1.74	0.87	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	37.96	7.77	0.90	1.20	0.90	0.60	2.99
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	44.26	6.64	1.66	1.11	1.11	2.21	2.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	35.35	4.24	2.47	0.35	1.77	0.71	3.53
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	46.84	4.06	4.06	1.11	0.00	1.11	5.16
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	24.18	1.15	1.15	1.15	1.15	0.00	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	29.55	1.54	2.30	0.38	0.00	0.00	5.37
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	36.23	2.83	2.83	1.13	0.57	0.00	5.66
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	27.08	1.64	0.82	0.82	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	31.63	2.26	1.36	0.90	2.26	1.81	4.97
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	30.88	2.15	2.87	1.44	0.72	2.15	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	32.86	2.24	4.48	0.75	0.00	0.75	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	29.36	4.46	3.34	0.37	0.37	0.37	2.60
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	31.01	3.02	1.29	0.43	0.86	0.43	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	27.40	0.86	0.86	0.00	3.43	1.71	5.99
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	27.32	2.67	1.67	0.33	1.33	1.33	3.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	26.55	3.62	3.02	0.00	1.21	0.60	4.83
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	24.88	3.55	2.84	0.71	0.71	0.71	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	19.25	2.75	1.37	0.69	1.37	1.72	3.44
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	24.15	3.22	2.15	0.00	2.68	0.54	2.68
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	20.87	2.02	2.69	0.00	2.02	0.67	4.04
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	25.93	3.70	3.33	0.74	1.48	0.37	3.70
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	22.10	2.33	4.65	0.00	0.00	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	19.04	1.06	1.06	0.00	2.12	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	33.21	3.20	2.40	0.80	2.40	1.20	4.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	41.43	2.18	1.45	0.00	0.73	1.45	4.36
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	29.13	3.07	3.07	0.77	0.00	1.53	7.67
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	32.56	1.97	1.97	0.00	2.47	0.49	2.96
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	38.58	2.82	0.94	0.00	0.94	0.00	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	30.67	4.02	3.02	0.50	1.51	1.01	5.03
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	33.80	2.70	0.90	0.45	2.70	0.45	4.96
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	34.42	1.72	3.44	0.00	0.00	1.72	10.33
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	28.95	2.67	3.12	0.45	0.89	0.45	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	32.06	1.56	2.74	1.17	1.17	1.17	4.69
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	31.67	1.98	1.98	0.00	1.32	1.32	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	31.65	3.63	1.56	0.00	3.11	0.52	6.23
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	33.26	2.63	2.19	2.19	0.88	1.31	3.50
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	44.17	3.91	1.68	0.00	0.56	1.68	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	38.86	5.30	3.09	0.88	0.88	1.32	2.65
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	35.10	3.86	1.93	2.31	0.00	1.16	3.47
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	49.62	3.54	2.53	0.51	1.01	1.01	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	47.58	3.84	0.48	0.00	1.92	1.92	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	42.54	2.78	1.99	1.19	1.19	1.19	2.78
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	44.36	6.68	0.61	1.22	0.61	1.22	3.65
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	34.59	0.69	2.77	0.00	0.69	1.38	6.23
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	37.24	4.18	1.90	1.14	3.04	0.76	2.66
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	44.93	2.07	0.52	0.52	1.03	3.10	3.10
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	36.28	1.21	4.23	0.60	2.42	1.21	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	38.35	6.97	2.22	0.95	0.95	1.58	3.80
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	46.91	5.86	0.53	2.67	2.13	0.53	5.33
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	35.63	1.15	1.15	2.87	0.57	2.87	8.05
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	44.22	6.69	1.54	1.03	2.06	3.09	7.20
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	35.37	2.83	1.41	1.41	0.00	0.71	4.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	33.48	0.57	3.40	0.57	2.84	1.70	6.81
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	38.27	5.41	1.66	0.00	1.66	0.83	2.91
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	43.85	2.35	0.78	0.78	1.57	0.00	5.48
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	28.39	0.84	2.51	1.25	0.84	2.09	4.18
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	39.96	4.18	3.25	0.93	1.39	1.86	8.36
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	26.09	2.01	3.35	2.01	0.00	0.67	4.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	32.08	2.14	2.67	0.53	0.53	2.14	5.88
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	25.05	2.42	0.81	0.40	0.40	1.62	5.25
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	25.70	2.75	1.84	0.00	0.00	0.92	5.51
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	27.56	1.78	1.78	0.00	2.67	0.89	4.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	26.78	2.85	2.28	0.00	0.57	2.85	9.12
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	34.51	0.77	2.30	0.77	3.83	0.00	8.44
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	21.34	1.09	1.64	0.00	0.55	0.55	7.11
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	19.60	0.89	2.23	1.78	0.89	2.67	5.79
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	26.26	4.42	1.82	1.30	1.30	1.04	3.38
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	27.19	0.66	0.66	3.32	0.66	0.00	9.95
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	22.86	2.08	6.24	2.08	4.16	0.00	8.31
Macrophage - monocyte derived, donor1	11232-116C8	33.96	1.82	1.37	0.46	0.91	0.91	0.46
Macrophage - monocyte derived, donor2	11313-117C8	42.94	6.06	0.18	0.00	0.00	0.73	0.18
Macrophage - monocyte derived, donor3	11389-118C3	38.28	4.59	0.52	0.66	0.26	0.39	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	26.02	1.06	0.00	0.53	0.00	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	32.64	1.43	0.63	2.22	0.00	0.32	0.00
Mallassez-derived cells, donor3	11930-125I4	28.77	1.81	1.25	0.97	0.14	0.83	0.00
Mammary Epithelial Cell, donor1	11273-116H4	7.97	0.40	1.49	1.49	0.60	0.10	0.00
Mammary Epithelial Cell, donor2	11350-117G9	12.16	0.00	0.29	0.87	0.58	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	4.49	0.25	0.75	0.25	0.25	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	53.56	4.75	0.00	2.71	0.00	2.03	0.68
Mast cell, donor1	11563-120D6	43.15	2.38	0.76	2.16	0.65	1.30	0.87
Mast cell, donor2	11565-120D8	48.74	3.86	3.86	17.24	0.59	1.78	0.59
Mast cell, donor3	11566-120D9	41.65	4.73	8.33	7.43	0.68	1.35	0.68
Mast cell, donor4	11567-120E1	47.51	4.08	6.56	9.04	0.35	1.95	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	45.80	2.77	2.11	1.89	0.11	2.22	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	52.53	2.92	1.17	1.75	0.00	1.17	1.17
Mast cell, expanded, donor5	11939-126A4	35.45	1.38	1.84	1.72	0.69	0.80	1.15
Mast cell, expanded, donor8	11941-126A6	36.99	2.01	1.67	3.01	1.51	0.67	1.67
Melanocyte - dark, donor1	11502-119F8	28.75	0.30	0.20	0.60	0.40	0.40	0.10
Melanocyte - dark, donor2	11582-120F7	18.34	1.38	0.00	0.35	0.00	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	25.35	1.67	0.43	0.58	0.72	0.43	0.14
Melanocyte - light, donor1	11274-116H5	7.29	0.24	0.00	0.24	0.47	0.00	0.24
Melanocyte - light, donor2	11351-117H1	4.78	0.00	0.68	0.00	1.36	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.94	1.73	0.00	0.00	0.87	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	23.12	1.25	0.73	0.31	1.46	0.21	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	16.41	1.08	0.54	0.54	0.00	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	26.52	2.14	0.80	0.54	1.34	0.27	0.27
Meningeal Cells, donor1	11493-119E8	14.51	0.12	0.25	0.12	0.00	0.62	0.12
Meningeal Cells, donor2	11573-120E7	10.12	0.00	0.44	0.00	0.44	0.44	0.00
Meningeal Cells, donor3	11654-122E7	28.36	1.39	0.00	0.82	0.16	0.90	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	15.97	1.71	0.29	1.43	1.43	1.43	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	21.64	1.81	0.40	0.91	0.30	0.50	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	0.00	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	0.00	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	10.05	0.72	0.00	0.00	1.44	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	22.87	1.69	0.42	0.64	0.85	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	19.10	0.50	0.50	0.00	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	5.93	0.00	0.44	0.44	0.00	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	3.65	0.00	0.73	0.00	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	8.80	0.82	0.61	0.20	0.20	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	26.73	0.69	0.42	0.42	0.42	0.69	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.58	0.00	0.74	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	29.60	1.97	0.53	0.66	1.05	1.05	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.34	0.59	0.00	0.30	0.30	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	9.61	0.64	0.00	0.00	0.64	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	14.53	2.13	0.71	0.35	0.35	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	26.27	2.81	0.94	0.63	0.63	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	12.34	1.45	0.73	0.73	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	21.74	2.12	0.80	0.80	0.53	0.53	0.00
Mesothelial Cells, donor2	12156-128G5	12.01	1.50	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	16.33	3.25	0.51	1.59	0.51	0.43	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	2.70	0.00	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	38.17	3.69	0.25	0.00	0.00	1.48	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	38.87	3.53	0.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	6.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	36.88	4.03	0.00	0.00	0.31	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	35.06	3.11	0.41	0.62	0.21	0.83	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	2.32	0.00	0.00	2.32	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	47.55	3.50	0.25	0.50	0.00	2.25	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	41.89	3.26	0.00	0.47	0.00	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	34.55	1.83	0.00	0.00	0.20	0.81	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	34.05	3.56	1.19	0.00	0.00	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.93	0.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	26.98	4.18	0.00	0.00	0.76	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	1.32	0.00	1.32	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	15.49	1.06	0.00	0.21	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	18.42	4.60	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	18.48	1.79	0.30	0.00	0.00	0.30	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	0.00	0.00	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	13.30	1.51	0.25	0.00	0.00	1.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	22.10	1.66	0.00	0.48	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	5.53	0.00	0.00	0.00	0.00	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	7.37	0.69	0.00	0.46	0.00	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	13.46	1.47	0.00	0.00	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	11.21	3.87	0.00	0.20	0.20	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	15.02	2.36	0.21	0.00	0.21	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	12.89	2.00	0.00	0.00	0.00	0.67	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	8.76	1.10	0.00	0.22	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	8.11	0.51	1.01	0.00	0.00	1.52	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	0.00	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	8.97	1.90	0.00	0.00	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	17.35	1.76	0.29	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	3.27	0.00	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	11.05	2.40	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	20.01	4.00	0.00	0.40	0.00	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	13.71	4.11	0.00	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	17.02	1.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	2.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	20.14	1.75	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	12.14	2.21	0.00	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	8.33	2.56	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	18.10	1.24	0.00	0.00	0.00	0.74	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.83	4.18	0.00	0.70	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	6.63	0.00	4.42	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	27.01	2.05	0.00	0.34	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	17.50	1.31	0.00	0.88	0.00	1.31	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	13.85	1.42	0.00	0.36	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	16.55	1.68	0.00	0.28	0.00	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	22.44	2.91	0.42	0.00	0.00	1.25	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	8.16	2.91	0.00	0.58	0.00	0.00	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	20.51	0.90	0.00	0.00	0.00	0.90	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	30.89	3.34	0.00	0.00	0.00	1.67	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	17.55	2.77	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	33.58	2.28	0.00	0.00	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	19.90	2.63	0.00	0.41	0.00	1.24	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	17.36	0.78	0.00	0.26	0.00	0.52	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	33.46	6.43	0.43	0.00	0.00	2.57	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	13.97	1.27	0.00	1.91	0.00	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	18.95	1.87	0.00	0.53	0.00	0.53	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	44.60	2.99	0.00	0.30	0.00	2.10	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	19.78	2.40	0.00	0.14	0.28	0.57	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	24.53	3.19	0.00	0.32	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	37.37	4.64	0.22	0.00	0.00	1.55	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	17.44	2.65	0.38	0.00	0.00	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	25.57	3.13	0.00	0.28	0.28	0.57	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	38.59	3.93	0.25	0.25	0.00	1.47	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	20.85	2.61	1.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	22.05	4.12	0.29	0.29	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	50.17	5.19	0.29	0.29	0.00	2.02	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	37.51	2.47	0.00	0.41	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	31.86	2.68	0.30	0.60	0.00	1.19	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	33.90	3.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	17.82	3.56	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	24.64	2.96	0.66	0.00	0.33	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	30.51	3.16	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	42.50	2.57	1.19	0.20	0.00	0.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	36.32	2.79	0.93	0.00	0.93	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	24.41	2.25	0.75	0.38	0.00	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	30.63	4.00	0.53	0.00	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	30.08	1.47	0.79	0.34	0.11	0.45	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	14.00	1.47	0.74	0.00	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	25.28	0.73	0.37	0.00	0.00	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	35.78	9.33	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	25.65	0.53	1.07	0.00	0.00	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	14.14	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	22.35	2.53	0.00	0.42	0.00	1.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	25.88	2.72	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4.45	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	5.67	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	25.68	4.53	4.53	0.00	0.00	1.51	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	91.36	5.71	22.84	5.71	0.00	17.13	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	48.94	9.79	0.00	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	9.50	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	12.55	12.55	0.00	0.00	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	19.39	1.08	0.65	0.65	0.43	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	14.11	1.05	0.52	0.00	1.05	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	27.37	4.00	0.67	0.67	0.67	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	21.29	4.59	0.42	0.00	0.42	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	17.49	1.90	0.00	0.19	0.19	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	30.32	3.19	1.60	3.19	1.60	3.19	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	24.48	3.40	0.68	0.68	1.36	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	9.19	5.51	0.00	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	16.32	2.09	0.84	0.84	1.67	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	20.92	2.56	0.46	0.46	0.23	0.93	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	21.62	4.86	0.27	0.81	0.54	0.81	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	28.59	2.52	0.63	1.05	0.84	2.10	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	0.00	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	24.82	2.98	0.00	0.50	0.50	2.48	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	17.05	0.27	0.00	0.81	0.54	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	19.72	2.49	0.91	0.45	1.36	0.68	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	21.39	5.23	0.16	0.33	0.33	0.65	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	22.42	2.00	0.55	0.55	1.46	0.91	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	22.81	4.77	0.00	0.00	0.00	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	33.02	2.40	1.20	3.00	0.60	1.80	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	12.80	1.31	0.00	1.31	0.00	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	16.10	5.20	0.65	0.65	1.30	0.81	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	18.17	2.82	0.88	1.41	0.71	0.71	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	28.83	5.63	2.11	0.00	0.70	2.11	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	28.50	2.30	0.46	0.00	0.46	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	32.13	6.43	0.32	0.64	1.29	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	9.66	0.69	0.69	0.69	0.34	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	22.76	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	21.61	1.56	0.89	0.67	0.22	1.11	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	24.98	3.81	0.42	0.42	0.85	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	16.85	2.61	0.24	0.95	0.47	0.47	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	33.48	12.02	0.00	0.00	1.29	1.29	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	22.33	7.33	0.00	1.00	1.33	2.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	22.09	2.25	0.45	0.90	1.80	0.90	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	21.82	2.78	0.40	0.00	0.40	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	37.15	6.50	0.00	0.00	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	26.11	1.89	0.76	0.38	0.76	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	23.46	6.84	0.65	0.33	1.30	1.63	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	24.84	6.97	0.87	0.44	0.44	1.74	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	24.88	2.71	1.36	1.36	0.45	1.36	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	25.58	6.17	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	25.26	8.64	0.00	0.66	3.32	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	33.23	3.97	0.50	1.49	1.49	1.49	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	20.29	9.19	0.38	0.38	0.38	1.15	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	24.80	3.63	1.81	1.81	1.81	1.51	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	23.87	2.65	0.44	1.11	0.66	1.11	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	39.30	8.81	2.71	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	40.88	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	46.34	4.88	1.22	1.22	0.00	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	22.66	8.81	0.63	0.00	0.00	1.26	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	19.07	7.57	0.91	0.61	0.30	2.12	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	30.85	5.54	2.37	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	12.47	2.27	0.00	1.13	1.13	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	22.73	2.48	0.25	1.49	0.25	0.12	0.12
Myoblast, donor2	11322-117D8	30.11	4.03	1.73	1.15	0.96	0.38	0.58
Myoblast, donor3	11398-118D3	30.77	4.20	0.67	2.19	0.50	1.18	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	25.10	3.94	0.58	1.46	0.00	0.58	0.15
Natural Killer Cells, donor1	11230-116C6	350.88	27.06	2.15	1.23	0.31	4.61	1.85
Natural Killer Cells, donor2	11311-117C6	327.79	31.06	0.90	0.90	1.51	5.43	0.60
Natural Killer Cells, donor3	11387-118C1	287.49	34.79	2.02	1.10	0.92	3.31	1.10
Neural stem cells, donor1	11275-116H6	58.80	2.54	0.36	0.36	0.00	1.09	0.36
Neural stem cells, donor2	11352-117H2	44.29	0.00	1.93	0.00	0.00	1.93	0.00
Neurons, donor1	11494-119E9	25.03	6.83	0.00	2.28	2.28	1.14	3.41
Neurons, donor2	11574-120E8	19.81	0.88	0.66	0.22	1.98	0.00	1.54
Neurons, donor3	11655-122E8	27.13	4.93	0.00	0.00	4.93	0.82	5.76
Neutrophils, donor1	11233-116C9	146.62	12.06	10.21	1.86	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	86.97	8.70	8.70	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	261.44	13.44	9.77	1.22	0.00	3.67	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	23.63	2.61	0.71	1.66	1.19	1.78	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	10.09	0.98	0.33	0.98	0.98	1.30	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	8.42	0.80	0.40	1.40	0.60	1.00	0.40
Olfactory epithelial cells, donor1	11933-125I7	23.13	2.34	0.55	0.83	0.96	0.96	0.41
Olfactory epithelial cells, donor2	11934-125I8	18.96	2.61	0.43	0.58	0.29	0.72	0.29
Olfactory epithelial cells, donor3	11935-125I9	19.98	0.68	1.25	0.45	0.45	0.34	0.34
Olfactory epithelial cells, donor4	11936-126A1	20.55	1.56	1.07	1.56	1.66	0.49	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	29.49	1.20	0.00	0.00	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	14.68	0.85	0.64	0.21	0.21	0.85	0.00
Osteoblast - differentiated, donor2	11353-117H3	6.86	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	4.97	0.00	0.62	1.86	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	4.30	0.59	0.20	0.39	0.39	0.20	0.00
Osteoblast, donor2	11354-117H4	22.47	0.70	0.00	1.40	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	14.57	2.49	0.18	0.53	0.00	1.42	0.00
Pancreatic stromal cells, donor1	11249-116E7	18.28	1.77	0.67	1.43	0.76	0.25	0.08
Pericytes, donor1	11491-119E6	3.56	0.11	0.22	0.00	0.00	0.11	0.00
Pericytes, donor2	11571-120E5	4.30	0.45	0.45	0.00	0.23	0.00	0.00
Pericytes, donor3	11652-122E5	4.27	0.20	0.00	0.00	0.20	0.20	0.00
Perineurial Cells, donor1	11499-119F5	20.23	1.24	0.57	0.90	0.45	0.79	0.00
Perineurial Cells, donor2	11579-120F4	27.24	1.93	1.29	0.92	0.28	1.01	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	211.64	12.43	3.51	0.96	0.00	4.46	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	179.48	19.34	2.94	1.22	0.00	1.47	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	252.75	26.27	2.20	1.55	0.91	3.75	0.26
Placental Epithelial Cells, donor1	11278-116H9	4.30	0.24	0.96	0.96	0.00	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	4.44	1.11	1.11	1.11	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	6.68	1.77	0.59	0.39	0.59	0.00	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	19.62	2.53	0.32	3.48	0.00	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	32.08	1.13	0.75	1.88	1.31	0.56	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	68.53	8.22	0.39	4.57	0.26	1.96	0.65
Preadipocyte - breast, donor2	11328-117E5	29.72	3.83	0.45	2.03	0.23	1.13	0.90
Preadipocyte - omental, donor1	11468-119C1	35.70	2.77	0.11	1.39	0.32	1.17	0.32
Preadipocyte - omental, donor2	11329-117E6	57.18	4.36	0.87	1.31	0.00	1.31	0.44
Preadipocyte - omental, donor3	11403-118D8	24.78	3.72	0.00	1.72	0.29	1.29	0.00
Preadipocyte - perirenal, donor1	11469-119C2	13.78	2.95	0.98	1.97	0.00	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	10.44	0.92	0.00	0.31	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	21.25	1.24	0.00	0.53	0.71	0.18	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	16.01	2.55	0.17	0.17	0.00	0.68	0.00
Preadipocyte - visceral, donor1	11280-116I2	21.80	2.51	0.37	1.40	0.47	0.19	0.00
Preadipocyte - visceral, donor2	11357-117H7	23.47	0.46	0.00	0.92	0.46	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	18.08	1.04	0.52	0.73	0.42	0.52	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	10.11	0.91	1.96	1.06	1.36	0.15	1.66
Prostate Epithelial Cells, donor2	11331-117E8	21.67	1.76	0.41	0.95	0.14	0.14	0.27
Prostate Epithelial Cells, donor3	11404-118D9	8.76	0.55	2.76	1.84	0.12	0.12	0.06
Prostate Stromal Cells, donor1	11254-116F3	11.39	1.25	0.34	0.46	0.46	0.00	0.00
Prostate Stromal Cells, donor2	11332-117E9	10.22	1.26	0.00	0.54	0.36	0.36	0.36
Prostate Stromal Cells, donor3	11405-118E1	11.05	2.40	0.63	0.21	0.63	0.94	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.03	0.36	0.73	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	27.66	1.04	0.97	1.11	0.42	0.21	0.14
Renal Epithelial Cells, donor1	11517-119H5	5.58	0.00	1.01	0.00	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	5.69	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	35.46	1.38	1.59	1.27	0.74	0.64	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	3.40	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.41	0.00	0.00	0.40	0.27	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	20.20	0.67	0.22	0.44	0.89	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	4.66	0.00	0.00	0.00	0.67	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	6.82	0.00	0.22	0.22	0.22	0.66	0.00
Renal Mesangial Cells, donor2	11598-120H5	7.52	0.00	1.88	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.33	0.00	0.28	0.28	0.00	0.00	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	12.08	0.27	0.27	0.27	0.27	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5.06	0.00	0.84	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	7.91	0.58	0.19	0.39	0.39	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	11.93	0.52	0.78	0.26	0.78	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	8.53	0.28	0.28	0.28	0.00	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	2.06	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	15.05	0.25	1.00	0.00	1.25	0.50	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	30.07	1.60	5.48	1.87	1.34	0.80	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	22.34	1.79	0.00	0.89	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	23.67	0.55	0.55	0.55	0.00	0.55	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	18.56	2.32	0.00	1.74	0.00	0.00	3.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	21.97	0.78	0.39	0.52	0.65	0.65	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	20.16	1.89	0.60	0.50	0.89	0.50	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	30.34	2.79	0.56	0.33	1.23	1.12	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	26.55	0.37	0.37	1.24	1.24	0.74	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	18.53	1.52	0.58	0.70	1.17	0.58	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	24.04	0.92	0.46	0.46	0.69	1.62	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	19.03	1.23	0.55	0.68	0.27	0.41	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	17.40	2.12	0.45	0.30	0.91	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	21.14	1.25	0.18	0.18	0.72	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	21.95	0.86	0.29	1.00	0.57	0.86	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	15.45	1.18	0.21	0.00	0.75	0.64	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	17.26	1.33	0.66	1.11	1.55	0.89	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	23.13	1.53	0.38	1.34	1.72	0.38	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	17.98	2.89	0.19	0.65	0.65	0.84	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	33.45	1.88	1.13	0.75	0.19	0.94	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	26.01	1.33	0.13	0.40	1.33	0.66	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	23.95	2.43	0.29	0.58	1.17	0.39	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	24.25	3.25	0.19	0.95	0.38	0.95	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	31.93	0.64	0.53	0.43	0.43	0.43	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	22.70	2.52	0.56	0.56	0.84	0.56	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	24.61	2.56	0.85	0.51	1.03	0.34	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	35.74	1.82	0.55	0.00	0.91	0.91	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	20.72	3.56	0.86	0.86	1.10	1.10	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	25.52	3.63	0.13	0.81	1.48	0.94	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	45.05	0.47	0.47	0.71	0.47	1.18	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	33.53	3.37	0.40	0.99	1.19	0.99	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	32.74	3.74	1.17	1.17	0.70	0.00	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	26.13	1.04	0.62	0.62	0.83	0.21	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	31.41	3.10	0.22	1.11	0.66	0.66	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	27.36	3.76	0.42	0.42	0.84	1.04	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	24.76	1.21	0.54	1.08	0.40	0.40	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	20.78	2.04	0.34	0.85	1.36	0.34	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	28.53	3.66	0.39	1.16	0.77	0.77	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	28.37	1.20	0.86	0.86	0.34	0.52	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	20.58	1.65	0.14	0.69	0.96	0.27	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	24.63	1.64	0.33	0.82	1.48	0.82	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	21.47	1.19	0.17	0.17	0.51	0.68	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	19.97	2.22	0.00	0.44	1.33	0.30	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	17.86	1.07	0.00	0.27	0.27	1.33	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	14.52	0.28	0.55	0.55	0.41	0.14	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	14.52	1.90	0.00	0.48	0.95	0.24	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	22.57	2.42	1.01	0.40	1.21	0.40	1.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	18.74	0.94	0.47	0.57	0.75	0.66	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	16.42	0.70	0.00	1.05	1.40	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	20.25	1.81	0.30	0.30	0.60	0.00	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	23.01	0.00	0.98	0.98	0.49	0.61	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	38.13	3.64	2.04	1.46	1.60	1.89	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	18.25	1.22	0.00	0.61	0.61	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	18.39	0.00	1.51	0.00	0.60	0.00	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	19.23	1.13	0.45	0.23	1.36	1.13	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	19.17	2.10	1.50	1.20	0.90	1.50	3.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	21.73	0.47	0.83	0.83	0.35	0.35	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	17.93	3.42	0.43	1.07	0.64	0.00	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	16.23	2.40	1.20	0.60	1.20	1.20	1.20
Schwann Cells, donor1	11498-119F4	4.33	0.00	0.56	0.38	0.19	0.00	0.00
Schwann Cells, donor2	11578-120F3	13.61	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	19.94	1.31	0.22	1.10	0.00	1.10	0.44
Sebocyte, donor1	11220-116B5	13.15	1.10	0.55	1.64	0.55	0.55	0.00
Sebocyte, donor2	11301-117B5	11.03	0.92	0.00	0.46	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	4.33	0.41	0.41	0.21	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	13.25	1.66	0.00	4.97	0.00	1.66	1.66
Sertoli Cells, donor2	11333-117F1	14.12	0.00	0.00	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	9.77	0.62	0.79	1.32	0.53	0.26	0.26
Skeletal Muscle Cells, donor2	11358-117H8	4.34	0.00	0.00	0.00	2.17	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	11.70	1.67	1.67	0.00	0.84	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	19.48	1.41	1.26	0.63	0.79	0.63	0.31
Skeletal Muscle Cells, donor5	11455-119A6	19.03	1.34	1.78	0.45	0.59	0.74	0.45
Skeletal Muscle Cells, donor6	11459-119B1	24.32	0.31	0.62	1.23	1.39	1.08	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	30.75	3.40	2.52	2.14	1.26	0.76	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	22.83	1.85	4.42	0.86	1.85	0.86	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	24.90	2.18	0.30	0.79	0.60	0.40	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	13.73	0.93	0.17	0.34	0.93	0.59	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	3.62	0.00	1.45	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	8.53	0.55	0.41	0.28	0.00	0.28	0.00
Skin - palm, donor1	10286-104F7	13.43	2.69	2.69	2.69	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	15.42	2.16	0.29	0.86	0.14	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	108.78	4.91	9.00	0.82	0.00	4.91	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	16.10	0.65	0.13	0.91	0.00	0.39	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	22.80	1.67	0.56	0.97	0.00	0.56	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	13.93	1.55	1.55	0.98	0.56	0.14	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	76.12	5.29	5.50	3.59	1.06	1.69	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	13.64	1.42	2.10	0.82	0.30	0.22	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	9.87	0.00	0.31	1.54	0.31	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.68	0.67	1.11	2.22	0.22	0.67	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	12.93	1.18	0.59	1.76	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	8.84	0.88	0.66	0.88	0.00	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	5.91	0.39	0.39	0.00	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	12.36	3.09	1.55	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	22.02	4.00	3.00	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	8.92	0.53	0.13	0.27	0.13	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	12.86	1.11	0.44	0.22	0.66	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	15.36	0.64	0.51	1.66	0.13	0.38	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	23.77	3.26	0.65	0.33	0.33	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	20.97	1.18	0.30	0.00	0.00	1.48	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	18.65	2.99	0.71	0.71	1.00	0.85	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.63	0.33	0.33	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	14.92	0.30	1.83	0.61	0.00	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	8.08	0.25	0.51	0.51	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	8.58	0.00	0.48	0.48	0.48	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	17.84	1.62	0.59	0.29	0.15	0.59	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	15.93	2.37	1.51	0.65	0.00	0.65	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	14.48	2.73	0.63	0.42	1.26	0.31	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	3.25	0.46	0.00	0.31	0.15	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	4.31	1.08	1.08	0.00	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	10.76	0.00	0.30	0.60	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	1.71	0.00	0.34	0.34	0.34	0.68	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	20.97	1.41	0.79	0.86	2.04	0.71	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	14.09	1.01	0.40	3.02	0.91	0.50	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	16.16	1.82	0.23	0.91	0.46	0.46	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3.62	0.00	1.21	0.60	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	16.69	1.32	0.26	0.79	0.26	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	13.85	0.40	0.53	0.67	0.67	0.13	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	13.65	1.13	1.13	0.38	0.13	0.50	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	11.41	1.78	0.25	0.00	0.00	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	13.12	0.90	0.15	1.66	0.30	0.30	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	6.75	0.75	0.75	2.25	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	41.35	2.58	0.00	0.00	0.00	2.58	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.95	0.47	0.93	0.47	0.93	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	9.59	0.00	0.00	0.50	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	14.42	0.31	0.31	1.57	0.00	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1.77	0.00	0.29	0.29	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	14.25	0.75	0.25	1.58	0.08	0.25	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.48	1.40	0.00	1.40	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	7.05	0.00	0.72	0.14	0.00	0.29	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	10.96	1.78	0.25	0.76	0.76	0.51	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	6.02	0.00	0.56	0.75	0.00	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	25.29	0.84	0.70	0.70	0.42	0.42	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	16.42	1.09	0.25	1.17	0.42	0.50	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.90	0.00	2.38	0.48	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	7.10	0.24	0.00	0.24	0.00	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	22.54	1.55	0.66	0.44	0.88	0.66	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	9.66	0.59	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	14.19	1.17	1.75	0.97	0.58	0.78	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	11.37	1.06	0.00	0.79	0.53	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	11.53	1.86	0.00	0.00	0.00	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	16.17	1.44	0.72	0.36	0.36	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	8.80	0.57	0.57	0.85	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	16.54	1.18	0.39	1.18	0.00	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	13.97	1.52	0.00	1.02	0.00	0.51	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	7.99	0.00	2.40	0.80	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	13.38	0.42	0.00	0.84	0.42	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	18.33	0.92	0.00	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	26.76	2.69	0.34	0.84	0.34	0.84	0.00
Synoviocyte, donor2	11368-117I9	19.28	3.35	0.84	2.68	0.67	0.84	0.00
Synoviocyte, donor3	11440-118H9	14.52	0.45	1.79	1.79	0.22	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	5.36	0.71	0.36	0.00	0.71	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	1.98	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	2.78	0.23	1.16	0.00	0.69	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	9.46	0.57	0.65	0.43	0.29	0.22	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	6.19	1.16	0.77	0.77	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	5.15	0.00	0.57	0.00	0.00	0.00	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	23.37	2.21	2.83	1.35	0.86	0.86	0.49
Urethra, donor2	10319-105A4	14.39	1.80	5.40	5.40	10.79	0.00	0.00
Urothelial Cells, donor1	11520-119H8	5.05	0.00	0.00	0.53	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	3.20	0.00	0.00	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	6.65	0.23	0.69	0.46	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	37.67	1.11	1.56	0.22	0.00	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	43.60	0.00	3.56	0.00	0.00	0.00	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	62.90	1.43	5.72	0.00	0.00	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	27.38	2.74	2.05	0.00	0.68	0.68	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	46.49	1.03	3.79	1.72	0.69	0.69	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	47.64	0.00	4.07	0.00	1.74	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	57.27	0.00	5.21	1.04	0.00	0.00	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	66.08	0.00	4.59	0.00	1.84	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	39.25	2.74	1.83	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	19.61	1.97	0.49	0.12	1.11	0.99	1.11
Wilms' tumor cell line:HFWT	10597-108E3	5.28	1.76	1.76	1.76	0.88	2.64	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	27.09	4.19	0.56	0.28	0.28	0.28	0.28
achilles tendon, donor2	10292-104G4	26.86	4.13	0.00	8.27	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	23.46	1.02	0.76	0.00	0.51	0.76	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	41.79	1.63	0.93	0.23	2.32	0.46	1.86
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	61.13	3.21	2.61	0.00	2.37	0.59	4.04
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	33.20	1.63	0.00	0.00	1.09	0.27	5.17
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	23.05	0.84	0.28	0.00	0.84	0.00	3.65
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	29.61	1.90	0.00	1.90	0.63	1.27	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	36.48	2.45	0.82	1.36	1.09	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	18.95	0.00	0.00	0.00	0.00	0.88	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	47.37	1.23	0.00	0.41	0.82	0.00	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	79.21	4.27	1.55	0.39	1.94	0.78	5.05
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	7.18	0.00	0.37	0.00	0.18	0.00	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	46.81	3.90	0.00	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	35.09	2.32	0.23	0.46	0.46	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	41.17	0.78	0.52	0.78	2.07	0.00	2.85
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	44.71	1.75	0.88	0.29	0.58	0.29	1.75
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	23.70	0.46	2.79	0.00	0.00	0.00	2.79
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	20.97	0.82	1.23	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	18.11	1.84	0.61	0.00	0.31	0.61	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	22.62	2.13	0.85	0.00	1.28	0.43	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	22.14	0.61	0.00	0.00	0.30	0.61	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	20.94	1.20	0.72	0.00	0.72	0.48	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	7.80	0.67	0.22	0.00	0.45	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	16.34	1.67	1.00	0.00	2.00	0.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	7.43	1.86	0.00	0.00	0.00	1.86	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	25.61	0.75	0.75	0.00	0.38	0.00	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	38.38	0.87	1.31	0.87	1.74	0.87	2.18
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	16.87	3.75	1.87	0.00	1.87	1.87	1.87
adenocarcinoma cell line:IM95m	10796-110I4	30.14	5.65	1.18	0.47	0.47	0.71	0.24
adipose tissue, adult, pool1	10010-101C1	26.53	0.31	2.48	1.09	2.33	0.47	0.16
adipose, donor1	10184-103D4	14.07	1.76	2.93	0.59	0.59	0.00	6.45
adipose, donor2	10185-103D5	6.08	0.41	1.22	1.22	2.84	1.22	4.46
adipose, donor3	10186-103D6	13.34	3.81	2.18	1.36	2.18	0.54	4.36
adipose, donor4	10187-103D7	18.20	15.60	0.87	0.00	1.73	2.60	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	14.68	3.31	1.89	0.47	5.05	1.42	2.21
adrenal gland, adult, pool1	10081-102A9	14.55	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	15.07	0.40	2.27	0.53	0.67	0.13	0.93
alveolar cell carcinoma cell line:SW 1573	10708-109H6	28.58	1.07	0.00	0.00	2.50	1.07	0.36
amniotic membrane cells, donor1	12235-129G3	17.39	1.62	2.32	3.48	0.00	0.00	0.46
amniotic membrane cells, donor2	12236-129G4	26.03	2.03	2.37	2.03	0.34	2.03	0.00
amniotic membrane cells, donor3	12237-129G5	15.02	0.29	7.37	1.47	0.88	0.59	0.29
amygdala - adult, donor10196	10167-103B5	13.04	2.37	0.00	0.00	2.37	1.19	1.19
amygdala, adult, donor10252	10151-102I7	22.30	1.42	3.85	1.01	5.88	0.41	3.24
amygdala, newborn, donor10223	10360-105E9	18.72	2.58	2.58	0.65	3.23	0.65	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	21.26	1.27	2.93	2.55	2.16	0.25	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	23.39	3.09	0.88	0.22	1.32	0.88	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	12.03	5.68	0.67	0.00	5.68	3.67	0.67
aorta, adult, pool1	10052-101G7	13.93	2.35	4.90	1.96	1.37	0.59	0.20
appendix, adult	10189-103D9	34.15	2.72	5.05	1.55	1.55	0.78	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	14.45	0.34	3.10	0.00	2.06	1.03	1.38
artery, adult	10190-103E1	17.66	1.36	4.08	2.72	2.72	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	31.29	2.17	0.72	1.45	1.01	0.72	0.58
b cell line:RPMI1788	10427-106D4	14.87	1.78	0.15	0.74	1.93	1.49	1.34
basal cell carcinoma cell line:TE 354.T	10702-109G9	25.80	0.83	0.00	1.39	0.00	0.83	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	19.35	1.49	0.69	2.18	0.00	0.20	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	11.38	1.34	1.34	1.17	1.00	0.33	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	19.01	1.68	2.80	0.56	0.56	1.12	0.56
bladder, adult, pool1	10011-101C2	16.95	1.41	4.24	3.37	1.30	0.33	0.11
blood, adult, pool1	10053-101G8	59.79	8.86	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	9.42	0.86	0.00	1.71	0.00	0.00	0.00
bone marrow, adult	10192-103E3	47.24	2.02	0.67	0.00	2.02	1.35	0.00
brain, adult, donor1	10084-102B3	10.25	0.00	1.03	0.00	1.03	0.00	1.03
brain, adult, pool1	10012-101C3	9.35	0.67	1.67	0.45	3.12	0.22	1.22
brain, fetal, pool1	10085-102B4	2.67	2.67	0.00	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	38.32	2.64	0.99	0.33	0.99	0.99	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	18.60	2.12	1.37	0.37	2.50	0.62	2.87
breast, adult, donor1	10080-102A8	34.09	3.16	3.16	5.05	1.89	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	20.45	0.76	1.02	0.51	0.51	0.00	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	25.36	3.40	2.16	0.31	0.31	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	21.87	2.30	0.92	0.23	0.23	0.46	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	14.04	1.94	1.45	0.24	0.97	0.73	0.00
carcinoid cell line:NCI-H1770	10703-109H1	2.35	0.00	0.47	0.47	3.29	0.00	1.88
carcinoid cell line:NCI-H727	10735-110B6	15.53	1.09	4.92	0.55	0.11	0.11	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	9.19	1.27	0.32	0.00	2.54	0.32	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	18.90	1.86	1.86	0.00	3.99	0.80	3.73
caudate nucleus - adult, donor10196	10177-103C6	9.21	0.00	3.45	1.15	5.76	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	17.07	1.00	3.01	0.50	8.20	0.33	4.52
caudate nucleus, adult, donor10258	10379-105H1	8.41	4.58	3.82	1.53	6.11	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	16.11	2.56	1.46	0.73	4.76	0.37	3.66
cerebellum - adult, donor10196	10173-103C2	29.13	0.00	2.91	0.00	5.83	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	32.67	0.85	1.71	0.64	11.74	0.43	3.63
cerebellum, adult, pool1	10083-102B2	8.62	0.34	0.69	0.34	4.14	0.69	0.34
cerebellum, newborn, donor10223	10357-105E6	18.27	0.83	4.98	0.83	10.79	0.00	8.30
cerebral meninges, adult	10188-103D8	13.36	2.52	1.26	0.25	1.51	0.76	0.25
cerebrospinal fluid, donor2	10294-104G6	10.23	0.73	0.73	0.00	2.92	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	13.80	1.29	1.58	1.58	0.29	0.29	0.29
cervical cancer cell line:ME-180	10553-107I4	15.74	2.15	2.65	1.49	0.99	0.50	0.00
cervix, adult, pool1	10013-101C4	21.00	1.05	3.57	4.09	4.62	0.31	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	15.75	1.25	0.56	0.56	0.70	1.11	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	14.37	1.31	1.31	1.31	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	21.25	2.24	3.73	0.75	1.99	0.62	1.99
choriocarcinoma cell line:SCH	10785-110H2	11.21	1.85	0.86	0.25	1.60	0.62	3.70
choriocarcinoma cell line:T3M-3	10618-108G6	8.78	0.71	2.61	0.00	0.24	0.71	0.71
chorionic membrane cells, donor1	12238-129G6	16.81	0.57	1.99	1.42	0.28	1.14	0.00
chorionic membrane cells, donor2	12239-129G7	27.05	4.08	1.09	2.29	0.30	0.80	0.30
chorionic membrane cells, donor3	12240-129G8	10.99	0.00	2.20	0.55	0.55	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	18.18	1.01	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	35.15	2.11	0.38	0.77	0.19	0.38	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	31.26	1.90	0.21	0.84	1.27	0.21	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	2.05	0.26	2.31	0.00	0.77	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	2.18	0.00	1.94	0.00	0.24	0.00	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	3.46	0.41	2.04	0.00	0.00	0.00	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	3.83	0.59	0.88	0.00	0.29	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	69.59	2.61	1.30	2.09	2.61	2.35	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	15.09	1.37	0.91	0.91	0.69	0.69	0.23
clear cell carcinoma cell line:TEN	10636-108I6	31.40	2.60	0.17	0.52	0.00	1.56	0.35
colon carcinoma cell line:CACO-2	10513-107D9	15.38	1.83	0.55	0.00	0.37	0.55	0.37
colon carcinoma cell line:COLO-320	10420-106C6	12.16	0.76	1.90	0.38	1.14	0.00	2.28
colon, adult, donor1	10082-102B1	19.04	0.00	4.76	0.00	2.38	0.00	1.19
colon, adult, pool1	10014-101C5	14.92	0.35	4.23	1.76	3.76	0.00	0.24
colon, fetal, donor1	10070-101I7	26.57	1.24	5.56	1.24	1.85	1.24	0.62
common myeloid progenitor CMP, donor1	12130-128D6	55.00	0.00	0.00	4.58	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	71.81	6.80	2.55	2.12	0.42	5.52	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	43.02	3.92	0.30	0.75	0.00	2.87	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	52.88	4.23	0.42	0.56	0.00	1.83	0.00
corpus callosum, adult, pool1	10042-101F6	13.93	1.11	2.43	0.77	4.31	0.00	1.33
cruciate ligament, donor2	10295-104G7	36.47	2.43	3.24	2.43	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	22.47	0.80	0.80	1.61	2.41	0.80	0.00
diencephalon, adult	10193-103E4	11.76	1.44	1.92	0.48	2.64	0.48	1.44
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	31.46	1.38	0.46	0.00	0.69	0.00	1.84
ductal cell carcinoma cell line:KLM-1	10438-106E6	30.52	0.77	2.82	0.26	0.00	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	12.28	1.69	0.48	0.48	0.24	0.24	0.48
ductus deferens, adult	10196-103E7	11.96	1.50	9.97	0.50	2.49	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	20.16	1.44	2.88	0.00	5.76	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	21.33	0.74	6.62	0.74	3.68	0.00	0.00
dura mater, adult, donor1	10041-101F5	28.49	3.22	0.83	1.40	1.57	0.91	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	17.32	2.22	5.77	0.89	0.89	0.89	2.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	10.32	1.15	0.57	0.00	0.86	0.43	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	11.72	2.47	0.62	4.32	0.62	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	16.65	2.42	1.21	0.30	0.91	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	12.97	0.93	0.93	1.23	0.31	0.93	0.00
embryonic pancreas cell line:2C6	10603-108E9	2.63	3.94	2.63	3.94	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	13.74	2.01	1.34	0.67	1.34	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	26.46	3.44	0.18	2.90	1.45	0.91	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	18.98	0.64	0.96	0.32	0.00	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	21.01	2.33	0.89	2.67	0.33	1.56	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	17.60	1.43	0.33	2.09	0.33	0.44	0.33
epididymis, adult	10197-103E8	19.05	2.30	4.19	0.84	1.26	1.05	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	17.56	1.24	0.89	1.77	0.53	0.53	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	11.01	1.57	0.00	0.00	0.39	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	18.61	2.23	0.66	1.18	0.92	0.26	1.31
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	16.83	1.67	1.28	0.20	0.49	0.59	1.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	17.92	2.80	0.45	1.01	0.45	0.78	0.45
esophagus, adult, pool1	10015-101C6	14.12	0.64	2.55	1.17	1.70	0.00	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	25.30	2.76	2.13	0.38	1.13	1.88	0.25
eye - muscle inferior rectus, donor1	10272-104E2	19.32	0.00	4.83	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	8.42	0.00	2.10	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	7.44	1.49	1.49	0.00	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	20.64	0.00	2.29	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	34.98	1.46	0.00	2.91	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	14.75	1.27	1.78	0.25	3.56	0.51	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	17.82	1.80	0.77	0.77	0.51	0.38	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	16.38	3.09	0.24	0.71	0.47	0.95	0.00
frontal lobe, adult, pool1	10040-101F4	12.95	0.66	1.50	0.38	5.35	0.66	1.31
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	34.83	4.50	2.40	2.10	0.60	0.90	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	13.17	1.46	1.55	0.91	0.09	0.46	0.37
gall bladder, adult	10198-103E9	16.42	0.97	3.38	1.45	1.21	0.00	0.97
gamma delta positive T cells, donor1	11937-126A2	103.08	6.44	5.91	0.00	1.07	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	151.64	10.83	1.49	1.49	0.37	2.61	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	15.00	0.42	0.42	0.21	0.00	0.42	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	17.79	0.58	1.93	0.77	0.58	0.39	0.58
gastric cancer cell line:AZ521	10549-107H9	19.35	1.15	1.80	0.49	4.43	0.16	2.13
gastric cancer cell line:GSS	10560-108A2	10.07	0.92	2.75	0.00	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	19.42	2.97	1.14	0.23	0.69	1.37	0.69
giant cell carcinoma cell line:LU65	10487-107B1	15.26	0.57	0.46	0.46	0.11	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	19.31	2.24	0.98	3.08	1.12	0.70	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	13.97	1.75	2.24	1.00	0.50	1.00	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	10.13	0.84	0.95	0.11	1.16	0.32	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	10.25	0.84	0.70	0.84	0.84	0.28	0.14
glioblastoma cell line:T98G	10485-107A8	16.00	1.43	1.10	0.44	0.22	0.33	0.22
glioma cell line:GI-1	10413-106B8	21.97	1.46	0.00	0.59	0.59	0.88	0.00
globus pallidus - adult, donor10196	10175-103C4	11.66	0.73	4.37	1.46	2.19	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	34.91	3.17	4.39	0.73	7.57	0.49	4.64
globus pallidus, adult, donor10258	10367-105F7	15.06	0.00	2.74	0.00	5.48	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	19.72	0.00	2.66	0.00	3.73	0.00	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	41.60	7.34	4.89	0.00	0.00	12.24	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	0.00	0.00	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	13.76	1.60	0.32	0.64	1.60	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	12.40	1.38	3.21	0.00	0.46	0.92	2.75
hIPS +CCl2, biol_rep2	14384-156C1	17.38	1.37	4.57	0.46	0.00	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	10.95	1.29	3.22	0.64	0.00	0.64	2.58
hIPS, biol_rep1	14380-156B6	14.37	1.44	1.44	0.00	0.00	1.44	5.75
hIPS, biol_rep2	14381-156B7	13.03	1.37	4.80	0.00	0.00	0.00	2.06
hIPS, biol_rep3	14382-156B8	9.93	0.00	2.21	1.10	0.00	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	27.01	4.60	0.00	1.15	0.29	1.44	0.57
heart - mitral valve, adult	10205-103F7	18.54	0.90	4.48	2.39	1.79	0.00	0.60
heart - pulmonic valve, adult	10206-103F8	20.13	1.57	4.71	0.52	3.14	0.52	0.78
heart - tricuspid valve, adult	10207-103F9	30.81	3.33	5.00	19.98	6.66	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	20.00	4.49	0.82	0.61	1.02	1.02	0.00
heart, adult, diseased, donor1	10051-101G6	8.09	0.43	0.43	0.85	1.28	0.00	0.00
heart, adult, pool1	10016-101C7	11.27	1.38	1.84	1.61	0.46	0.46	0.23
heart, fetal, pool1	10046-101G1	18.48	1.44	7.50	1.13	1.54	0.82	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	24.37	5.55	0.00	1.54	0.93	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	22.59	3.57	2.38	0.00	1.19	1.19	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	13.15	1.22	0.22	0.44	0.22	0.11	1.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	11.41	1.82	0.00	0.61	1.46	0.36	2.43
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	14.75	1.31	0.30	0.51	1.72	0.00	2.32
hepatoma cell line:Li-7	10484-107A7	10.12	1.11	1.11	0.44	0.33	0.89	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	9.55	0.50	0.20	0.00	0.40	0.00	1.01
hippocampus - adult, donor10196	10169-103B7	9.46	0.00	0.00	0.95	1.89	0.95	1.89
hippocampus, adult, donor10252	10153-102I9	28.17	2.86	7.14	0.61	7.76	0.61	3.06
hippocampus, adult, donor10258	10374-105G5	17.43	1.00	3.49	0.00	0.00	1.00	0.50
hippocampus, newborn, donor10223	10363-105F3	14.10	1.76	1.06	0.35	3.52	1.06	1.76
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	23.19	0.61	0.00	1.22	1.22	0.61	7.32
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	14.53	1.37	2.55	0.20	2.16	1.18	2.95
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	17.26	0.76	2.03	0.00	3.55	0.25	2.79
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	15.79	1.69	3.95	0.00	1.69	0.00	6.20
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	16.27	1.81	3.10	0.00	2.32	1.81	5.68
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	15.18	1.52	3.42	0.38	3.04	0.76	6.45
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	10.51	1.75	1.46	0.29	2.04	1.17	11.97
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	10.99	0.65	2.37	0.00	4.95	0.86	7.54
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	20.44	1.67	1.25	0.83	4.59	0.83	6.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	22.97	1.66	0.71	0.47	1.18	0.47	1.66
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	15.91	2.25	1.13	0.96	2.57	0.80	4.02
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	19.53	3.37	0.67	0.00	2.69	1.35	4.04
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	9.23	2.19	1.25	0.16	1.72	1.41	3.29
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	11.30	0.98	1.47	0.00	1.47	0.00	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	6.11	0.00	2.62	0.00	0.87	0.00	6.11
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	16.99	2.29	3.44	0.19	3.63	1.15	3.25
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	23.11	2.18	3.49	0.44	1.74	2.62	3.92
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	13.99	2.00	3.00	0.00	2.00	1.00	7.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	8.67	1.70	1.88	0.57	1.88	0.57	1.51
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	13.64	1.36	0.91	0.91	2.73	0.45	5.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	7.20	0.94	1.25	0.31	2.19	0.31	7.52
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	13.55	1.63	0.98	0.00	1.63	0.33	4.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	12.77	1.45	2.03	1.45	2.32	0.87	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	15.84	2.39	1.79	0.00	4.78	0.90	4.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	15.52	1.11	2.77	0.00	2.59	0.92	4.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	11.98	2.57	5.14	0.29	3.14	1.14	3.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	18.78	2.45	2.45	0.00	0.82	0.00	4.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	11.62	0.70	3.17	0.00	2.46	1.06	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	13.94	0.95	4.43	0.00	2.85	0.63	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	16.95	1.51	1.51	0.00	2.12	0.30	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.41	0.52	2.59	0.52	2.59	1.55	6.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	11.29	0.66	1.33	0.66	1.99	0.66	5.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	8.47	1.28	1.80	0.26	2.31	0.77	3.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	19.17	0.77	0.26	0.00	2.05	0.51	4.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	20.45	1.51	1.51	0.00	3.03	2.27	6.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	22.18	2.35	1.34	0.67	3.36	0.00	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	13.28	1.69	5.07	0.48	3.38	0.48	5.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	14.26	1.34	6.68	0.00	3.12	0.89	4.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	11.22	1.95	5.85	0.00	1.95	0.49	3.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	17.42	0.61	4.89	0.31	3.97	0.00	4.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	48.80	9.76	3.25	0.00	3.25	0.00	13.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	19.53	0.66	2.98	0.00	1.65	0.66	1.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	14.23	0.00	2.74	0.00	3.83	0.55	10.40
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	8.69	1.81	1.81	0.36	3.26	0.00	8.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	5.69	0.36	1.78	0.00	3.20	0.36	9.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	15.51	0.00	2.39	0.00	1.19	1.19	9.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	16.12	1.63	1.35	0.27	1.63	1.08	4.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	9.70	1.35	1.62	0.54	1.89	0.81	6.20
immature langerhans cells, donor1	11904-125F5	71.43	5.57	0.73	2.91	0.00	1.21	0.00
immature langerhans cells, donor2	11905-125F6	54.66	2.38	4.75	1.58	0.00	1.58	0.00
insula, adult, pool1	10039-101F3	10.13	1.14	1.61	0.19	4.83	0.00	1.51
keratoacanthoma cell line:HKA-1	10791-110H8	13.98	4.55	2.60	1.30	2.28	0.33	0.00
kidney, adult, pool1	10017-101C8	22.43	2.50	2.20	0.80	1.00	0.60	0.20
kidney, fetal, pool1	10045-101F9	19.24	2.12	2.90	0.71	1.34	0.42	0.78
large cell lung carcinoma cell line:IA-LM	10509-107D5	22.16	1.14	2.41	4.83	1.42	0.99	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	7.60	0.55	1.94	1.66	0.28	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	12.84	2.75	2.02	1.10	0.37	0.37	0.00
left atrium, adult, donor1	10079-102A7	11.44	0.00	2.18	1.09	0.00	0.00	0.54
left ventricle, adult, donor1	10078-102A6	9.61	1.52	2.02	1.52	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	19.70	4.38	0.55	0.82	0.27	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	1.08	1.08	0.36	0.36	0.36	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	7.07	0.54	0.00	0.54	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	11.17	1.46	0.24	0.97	0.73	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	12.55	3.14	1.05	0.00	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	22.55	2.24	0.35	0.59	0.71	0.83	1.06
liposarcoma cell line:KMLS-1	10782-110G8	18.90	2.03	0.94	1.09	1.25	0.47	0.16
liposarcoma cell line:SW 872	10726-110A6	21.20	4.87	1.83	1.22	0.73	1.83	1.10
liver, adult, pool1	10018-101C9	15.40	0.16	1.13	0.49	0.65	0.16	0.16
liver, fetal, pool1	10086-102B5	8.47	0.94	2.82	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	18.67	1.02	3.06	0.87	5.40	0.87	1.02
locus coeruleus, adult, donor10252	10165-103B3	16.98	1.48	3.69	0.55	5.72	0.00	3.51
locus coeruleus, adult, donor10258	10375-105G6	9.87	1.69	3.39	0.00	2.82	0.00	1.13
locus coeruleus, newborn, donor10223	10362-105F2	14.72	1.26	1.26	0.00	1.26	0.42	3.36
lung adenocarcinoma cell line:A549	10499-107C4	7.06	1.25	0.69	0.28	0.00	0.42	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	12.41	1.38	2.76	0.00	0.69	1.38	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	18.19	3.30	1.85	1.05	0.26	0.40	0.79
lung, adult, pool1	10019-101D1	19.14	1.42	2.84	1.65	1.89	0.24	0.35
lung, fetal, donor1	10068-101I5	33.11	0.86	10.56	0.57	2.57	1.14	0.86
lung, right lower lobe, adult, donor1	10075-102A3	31.16	4.12	3.67	1.83	4.12	0.46	0.00
lymph node, adult, donor1	10077-102A5	31.72	2.37	2.37	0.95	0.47	1.42	0.00
lymphangiectasia cell line:DS-1	10727-110A7	19.07	3.29	1.32	0.44	0.22	0.66	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	34.26	3.62	0.45	0.45	0.15	1.06	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	36.53	0.00	0.85	2.55	1.70	0.00	1.70
mature adipocyte, donor1	12231-129F8	7.99	0.89	4.00	0.00	0.89	0.44	0.00
mature adipocyte, donor2	12232-129F9	10.17	1.25	3.32	0.62	2.08	0.21	0.21
mature adipocyte, donor3	12233-129G1	8.06	1.19	3.79	1.42	2.37	0.47	0.24
mature adipocyte, donor4	12234-129G2	11.58	0.53	2.90	0.26	1.05	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	20.73	1.19	3.81	0.24	0.24	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	13.54	1.13	0.00	0.00	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	27.40	2.57	1.47	0.74	7.36	0.74	4.23
medial frontal gyrus, adult, donor10258	10368-105F8	11.44	0.32	1.27	0.00	4.13	0.95	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	12.79	2.56	1.71	0.85	0.43	0.00	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	10.80	1.18	2.19	0.17	4.39	0.68	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	30.14	2.55	3.40	0.85	10.40	0.00	3.18
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	0.00	5.78	0.00	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	13.64	1.44	0.36	1.44	3.59	1.08	2.51
medulla oblongata - adult, donor10196	10174-103C3	20.77	3.24	3.89	0.65	3.24	1.30	0.65
medulla oblongata, adult, donor10252	10155-103A2	28.95	1.86	3.72	0.93	4.18	0.46	3.72
medulla oblongata, adult, pool1	10038-101F2	11.51	0.90	2.20	0.98	3.67	0.08	1.06
medulla oblongata, newborn, donor10223	10361-105F1	12.85	0.69	3.82	0.69	5.21	0.35	1.04
medulloblastoma cell line:D283 Med	10838-111E1	16.38	0.89	4.21	0.22	3.54	1.55	3.76
medulloblastoma cell line:ONS-76	10759-110E3	7.58	0.86	0.49	0.49	0.61	0.49	0.24
melanoma cell line:COLO 679	10514-107E1	8.62	1.15	2.16	1.01	0.72	0.57	0.29
melanoma cell line:G-361	10465-106H6	11.67	1.09	1.90	1.36	0.54	0.54	0.54
meningioma cell line:HKBMM	10691-109F7	10.31	1.45	0.18	1.45	0.18	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	16.74	2.64	1.76	0.88	12.34	0.88	10.57
merkel cell carcinoma cell line:MS-1	10844-111E7	40.44	5.18	1.04	0.00	3.63	1.30	1.56
mesenchymal precursor cell - adipose, donor1	11747-123G1	19.64	1.07	0.31	0.00	0.46	1.38	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	14.36	1.09	0.18	0.18	0.73	0.55	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	17.81	0.83	0.00	0.41	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	17.84	1.40	0.14	0.14	0.14	0.42	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	18.29	1.54	0.19	0.19	0.19	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	12.49	0.69	0.69	2.08	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	7.21	0.34	0.69	2.23	0.51	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	14.95	0.92	0.23	0.92	0.58	0.58	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	17.77	0.53	0.40	0.93	0.13	0.66	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	19.04	1.08	0.14	1.22	0.68	0.54	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	20.91	0.43	0.14	0.57	0.43	0.43	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	14.82	0.99	1.32	1.32	0.33	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	17.71	1.25	0.42	0.97	1.38	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	12.92	1.40	0.00	0.70	0.00	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	14.50	0.20	0.41	1.22	0.20	0.61	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	19.41	2.52	0.36	1.44	1.08	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	13.03	0.72	0.21	1.45	0.41	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	14.82	0.68	0.23	0.46	0.68	0.46	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	17.62	0.84	0.00	2.10	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	21.82	1.64	0.30	0.30	0.45	0.45	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	15.32	0.96	0.35	0.96	0.26	0.61	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	21.72	1.84	0.00	0.37	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.60	2.29	0.29	2.00	0.29	1.14	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	26.52	3.37	0.42	1.26	0.42	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.98	1.83	0.00	1.83	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	19.44	1.53	0.26	3.84	0.77	0.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	22.77	2.09	0.26	4.19	0.00	0.52	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	19.10	1.54	0.00	3.08	0.62	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	20.24	0.94	0.47	4.24	0.47	0.47	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	24.37	1.35	0.68	2.03	0.68	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	18.08	0.39	0.39	2.75	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	14.36	0.00	0.46	2.32	0.00	0.00	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	15.86	0.29	1.73	1.73	0.58	0.87	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	17.85	2.01	0.89	3.35	0.45	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	17.79	1.44	1.44	3.61	0.48	0.48	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	13.93	0.73	3.67	0.00	1.47	2.20	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	19.80	0.67	0.67	2.69	0.34	0.67	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	13.51	0.82	0.82	2.87	0.41	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	12.46	2.15	0.86	2.58	0.86	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5.47	0.00	0.00	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	0.00	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	9.09	1.62	0.97	0.97	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	18.91	1.45	0.00	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	13.33	1.60	1.60	2.67	1.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	14.72	0.00	3.27	1.64	0.82	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	9.33	0.78	0.00	1.17	0.00	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	8.94	0.99	0.00	0.99	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	13.64	1.19	0.59	1.78	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	14.62	1.22	0.00	1.22	0.00	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	15.83	0.00	0.63	1.90	0.63	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	13.80	0.69	0.00	1.03	1.72	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	0.00	0.00	0.00	2.15	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	0.00	0.00	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	7.74	2.04	0.00	0.41	0.00	0.41	2.04
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	9.53	0.79	0.00	0.79	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	16.51	0.00	2.36	0.00	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	12.16	0.62	1.87	0.00	0.94	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	10.69	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	18.92	1.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	17.98	0.00	0.00	0.00	0.00	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	17.21	1.38	1.38	0.00	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	12.86	1.98	1.48	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	0.00	0.00	0.00	0.00	2.24	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	9.54	0.64	1.27	0.00	2.54	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	12.49	0.81	0.40	0.00	0.40	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	0.00	2.18	0.00	2.18	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	5.07	1.27	0.00	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	9.10	0.00	0.61	0.00	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	9.04	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	2.47	0.00	3.29	0.00	1.65	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	21.63	1.79	1.59	0.20	0.99	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	19.15	3.89	0.32	0.65	1.30	0.65	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	21.39	4.07	1.02	1.02	2.04	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	13.93	1.55	0.77	0.77	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	7.09	2.13	0.94	0.94	0.71	0.47	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	12.97	2.32	0.23	0.46	0.70	0.46	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	11.20	1.13	0.21	0.82	0.10	0.21	0.62
mesothelioma cell line:Mero-25	10850-111F4	11.80	0.68	1.59	0.23	1.13	0.00	0.45
mesothelioma cell line:Mero-41	10851-111F5	14.67	1.47	0.98	0.49	0.98	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	12.40	0.89	0.89	0.44	0.66	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	11.83	2.10	0.79	0.53	0.26	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	12.09	1.19	0.34	2.04	1.36	0.34	1.02
mesothelioma cell line:Mero-84	10855-111F9	12.64	0.51	2.02	1.52	0.00	0.25	0.76
mesothelioma cell line:Mero-95	10856-111G1	15.94	1.24	0.41	0.62	1.45	0.62	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	10.60	0.83	0.00	2.32	0.00	0.66	0.17
mesothelioma cell line:NCI-H226	10846-111E9	9.77	1.27	0.00	0.72	0.54	0.54	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	8.88	0.17	0.51	0.68	1.37	0.00	0.34
mesothelioma cell line:NCI-H28	10845-111E8	18.32	0.76	1.53	1.02	0.25	0.25	0.25
mesothelioma cell line:No36	10857-111G2	9.79	2.61	0.33	0.65	0.33	0.33	0.65
mesothelioma cell line:ONE58	10858-111G3	17.34	1.08	0.27	1.08	0.27	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	22.26	0.58	0.00	0.19	0.00	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	25.77	1.34	0.24	0.24	0.12	0.24	0.12
migratory langerhans cells, donor3	11903-125F4	28.18	2.69	0.72	0.54	0.36	0.36	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	18.61	3.59	0.98	1.96	0.33	0.00	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	14.62	2.54	0.00	2.54	2.12	2.12	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	8.98	0.92	0.46	1.15	0.23	0.23	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	36.73	5.90	0.38	0.00	0.00	2.28	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	19.03	0.18	0.37	0.37	0.37	0.00	0.74
myeloma cell line:PCM6	10474-106I6	17.20	1.19	0.40	2.57	0.20	1.19	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	8.62	2.03	1.01	0.00	0.51	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	13.34	0.59	0.20	5.10	0.39	0.78	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	11.59	0.78	1.56	0.78	0.00	0.45	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	10.81	0.66	1.03	0.81	0.15	0.22	0.07
nasal epithelial cells, donor2	12227-129F4	18.77	4.97	0.55	0.00	0.00	1.66	0.00
neuroblastoma cell line:CHP-134	10508-107D4	10.81	2.30	2.07	0.46	3.22	0.46	5.06
neuroblastoma cell line:NB-1	10539-107G8	24.51	1.68	1.12	0.19	0.56	1.12	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	13.71	1.27	1.05	0.00	1.05	0.21	1.90
neuroblastoma cell line:NH-12	10555-107I6	27.39	2.98	2.80	0.00	2.24	1.12	4.47
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	28.94	1.66	0.47	0.00	5.69	0.24	6.64
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	26.29	3.96	1.27	0.00	5.86	1.11	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	29.38	1.61	0.20	0.20	3.02	0.20	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	20.98	3.18	0.00	0.00	2.54	1.27	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	19.70	2.13	0.53	1.06	1.06	1.33	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	0.00	0.00	0.00	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	38.39	1.35	2.88	0.00	0.85	0.00	1.86
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	16.01	0.80	0.80	0.80	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	26.61	4.17	0.00	0.00	1.28	2.56	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	21.81	1.31	0.79	0.79	0.26	0.00	0.26
nucleus accumbens, adult, pool1	10037-101F1	13.31	1.41	2.16	0.19	4.41	0.47	0.75
occipital cortex - adult, donor10196	10172-103C1	16.48	0.00	2.06	0.00	2.06	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	41.60	3.22	4.56	1.07	11.00	0.54	5.90
occipital cortex, newborn, donor10223	10355-105E4	17.83	2.55	1.82	1.09	4.37	0.73	2.18
occipital lobe, adult, donor1	10076-102A4	13.12	2.62	1.57	0.79	7.35	0.79	0.00
occipital lobe, fetal, donor1	10073-102A1	30.90	2.15	0.86	0.86	8.15	0.86	1.72
occipital pole, adult, pool1	10036-101E9	6.94	0.71	0.47	0.00	2.60	0.16	0.71
olfactory region, adult	10195-103E6	9.74	0.76	2.10	0.38	3.25	0.19	1.72
optic nerve, donor1	10277-104E7	20.01	0.00	6.00	2.00	10.01	0.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	14.92	1.14	1.71	0.34	2.73	0.11	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	11.13	1.51	1.10	0.14	0.27	0.41	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	26.41	3.22	0.85	3.05	0.17	1.19	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	10.97	1.04	1.85	0.35	0.12	0.12	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	14.11	0.59	0.29	2.35	0.00	0.88	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	21.49	1.87	0.93	2.80	0.00	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	37.32	4.67	1.06	0.21	0.21	0.64	0.21
ovary, adult, pool1	10020-101D2	12.58	0.96	1.22	2.36	2.97	0.52	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	13.02	2.20	0.73	2.02	1.10	0.37	0.37
pancreas, adult, donor1	10049-101G4	4.70	0.00	4.70	0.94	1.88	0.00	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	31.03	7.55	1.40	0.00	0.56	1.40	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	11.75	0.68	1.19	1.36	0.00	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	46.69	4.80	2.32	3.64	0.00	0.83	0.33
paracentral gyrus, adult, pool1	10035-101E8	13.36	1.28	0.82	0.27	4.48	0.64	1.01
parietal cortex, adult, donor10258	10373-105G4	8.81	3.67	2.94	0.00	1.47	0.73	2.20
parietal lobe - adult, donor10196	10171-103B9	7.52	2.82	0.94	0.94	3.76	0.00	1.88
parietal lobe, adult, donor10252	10157-103A4	30.50	2.28	2.85	1.14	9.41	0.86	2.00
parietal lobe, adult, pool1	10034-101E7	12.60	1.06	1.41	0.26	4.58	0.26	0.88
parietal lobe, fetal, donor1	10072-101I9	32.00	1.94	1.94	0.00	6.79	0.00	7.76
parietal lobe, newborn, donor10223	10356-105E5	15.33	1.87	1.87	1.12	1.87	1.87	3.36
parotid gland, adult	10199-103F1	20.97	0.62	0.00	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	22.56	0.00	2.69	4.83	2.69	0.54	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	5.02	0.19	0.74	0.19	0.74	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	26.95	2.48	0.29	0.44	0.44	0.73	0.15
pineal gland - adult, donor10196	10179-103C8	7.10	1.29	5.81	1.94	3.23	1.29	1.29
pineal gland, adult, donor10252	10160-103A7	23.69	1.78	3.55	0.59	4.74	0.59	2.96
pineal gland, adult, donor10258	10377-105G8	13.17	0.63	5.02	0.00	3.76	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	12.14	3.04	4.05	0.00	2.02	2.02	1.01
pituitary gland, adult, donor10252	10162-103A9	39.09	2.61	18.24	1.56	8.86	0.52	1.04
pituitary gland, adult, donor10258	10378-105G9	11.07	2.55	5.96	0.00	2.55	0.00	0.85
placenta, adult, pool1	10021-101D3	21.07	1.94	3.12	0.97	0.75	0.86	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	21.85	1.85	0.26	0.53	0.26	0.66	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	23.81	1.25	0.78	0.62	0.16	0.16	0.16
pons, adult, pool1	10033-101E6	16.52	1.38	1.98	0.69	3.53	0.52	0.95
postcentral gyrus, adult, pool1	10032-101E5	8.80	0.78	0.44	0.09	2.35	0.17	1.13
promyelocytes/myelocytes PMC, donor1	12132-128D8	12.55	2.09	2.09	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	17.04	4.37	1.17	1.17	1.31	1.02	0.15
prostate cancer cell line:PC-3	10439-106E7	25.95	2.54	2.72	7.08	2.54	0.73	0.36
prostate, adult, pool1	10022-101D4	21.68	1.45	6.35	3.08	2.45	0.27	0.82
putamen, adult, donor10196	10176-103C5	9.44	1.42	2.83	0.24	5.19	0.24	1.18
putamen, adult, donor10252	10152-102I8	17.65	0.00	1.96	1.96	7.84	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	20.76	1.09	3.28	0.00	0.00	0.00	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	9.18	0.97	1.21	0.24	3.87	0.97	0.24
putamen, newborn, donor10223	10365-105F5	13.49	1.50	0.75	0.75	2.25	0.75	2.25
rectal cancer cell line:TT1TKB	10469-106I1	11.93	2.62	1.16	0.29	1.45	0.00	0.58
rectum, fetal, donor1	10067-101I4	43.12	4.17	9.74	1.39	5.56	0.00	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	15.90	0.64	1.06	0.00	0.42	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	4.97	1.24	0.41	1.66	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	15.01	1.09	3.98	0.80	2.78	0.30	0.70
retinoblastoma cell line:Y79	10475-106I7	7.01	1.30	0.26	0.00	4.42	1.04	2.34
rhabdomyosarcoma cell line:KYM-1	10787-110H4	14.51	3.20	0.98	0.37	3.93	1.72	2.46
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	18.84	1.12	1.41	0.00	0.28	0.84	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	15.16	0.00	0.76	2.27	1.52	0.76	0.00
salivary acinar cells, donor1	11771-123I7	15.54	1.13	2.59	1.46	0.49	0.49	0.16
salivary acinar cells, donor2	11772-123I8	9.64	0.55	4.68	3.17	1.24	0.69	0.28
salivary acinar cells, donor3	11773-123I9	19.20	0.00	1.32	4.63	1.99	1.99	0.66
salivary gland, adult, pool1	10093-102C3	16.59	0.57	5.15	0.00	0.57	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	15.01	0.84	0.34	1.10	0.84	0.25	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	13.40	0.47	0.71	0.47	1.65	0.35	0.24
seminal vesicle, adult	10201-103F3	20.63	1.59	10.05	1.06	2.12	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	15.30	1.94	6.07	0.73	0.49	0.97	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	20.89	4.03	2.01	0.50	0.00	0.75	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	16.06	0.00	0.00	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	42.18	5.91	1.48	2.42	0.81	2.28	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	13.59	0.55	0.22	0.55	0.00	0.11	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	20.52	1.42	1.29	1.16	0.39	0.13	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	4.97	0.71	4.26	1.42	1.42	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	14.15	0.48	1.92	0.72	1.32	0.12	0.12
skeletal muscle, fetal, donor1	10066-101I3	15.08	1.01	0.00	0.00	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	20.36	6.79	13.57	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	30.30	4.42	5.68	0.63	1.89	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	26.35	2.33	2.33	0.00	1.67	0.33	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	30.57	3.47	1.26	0.63	2.52	0.63	4.10
small cell lung carcinoma cell line:DMS 144	10841-111E4	11.56	1.16	0.19	0.00	3.85	0.19	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	17.97	1.32	4.29	0.16	0.66	0.49	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	8.04	0.32	4.66	0.16	0.48	0.48	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	43.58	0.65	4.58	0.44	0.87	0.00	0.44
small intestine, adult, pool1	10024-101D6	17.80	0.60	2.87	0.60	1.43	0.12	0.12
small intestine, fetal, donor1	10064-101I1	23.34	3.19	1.23	0.25	1.97	0.49	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	43.60	0.51	3.08	0.00	2.05	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	13.18	1.29	6.72	0.78	3.88	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	9.92	1.34	5.63	0.00	1.07	0.54	1.34
spinal cord - adult, donor10196	10181-103D1	20.19	0.92	4.59	0.69	5.05	0.23	1.84
spinal cord, adult, donor10252	10159-103A6	34.70	3.15	8.28	2.37	5.91	0.39	3.94
spinal cord, adult, donor10258	10369-105F9	16.60	0.00	5.53	1.38	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	20.73	6.71	4.27	1.83	3.05	1.83	1.22
spinal cord, newborn, donor10223	10359-105E8	25.72	2.30	5.97	1.38	1.38	0.46	3.67
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	20.31	1.19	0.75	3.73	0.15	1.05	0.00
spleen, adult, pool1	10025-101D7	38.88	3.30	1.10	1.43	0.99	0.55	0.44
spleen, fetal, pool1	10044-101F8	28.60	1.27	1.43	2.22	0.87	0.56	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	12.73	1.14	0.41	0.41	0.52	0.83	1.24
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	15.19	2.09	0.19	0.76	0.95	1.90	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	33.90	5.59	0.00	1.40	1.05	1.75	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	15.64	1.95	3.91	1.95	0.78	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	28.70	1.91	1.58	2.70	0.45	0.45	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	5.51	0.85	1.69	0.00	2.12	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	27.08	2.96	0.42	1.27	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	27.77	4.27	2.14	1.07	1.07	2.14	0.00
submaxillary gland, adult	10202-103F4	33.04	0.57	3.99	0.57	0.57	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	36.35	2.28	5.19	0.62	5.19	0.00	7.48
substantia nigra, adult, donor10258	10371-105G2	11.90	1.03	3.62	0.00	0.00	0.52	1.03
substantia nigra, newborn, donor10223	10358-105E7	23.32	0.00	5.65	1.41	2.83	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	18.11	1.83	0.23	0.00	2.75	0.92	1.83
temporal lobe, adult, pool1	10031-101E4	5.76	0.85	0.76	0.17	1.95	0.08	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	19.94	3.56	2.14	0.00	7.83	1.42	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	18.02	0.00	2.20	0.00	0.88	0.88	0.44
tenocyte, donor1	11763-123H8	18.15	1.40	0.35	1.75	0.70	0.00	0.00
tenocyte, donor2	11765-123I1	24.03	1.14	1.53	3.82	1.14	0.76	0.00
tenocyte, donor3	11768-123I4	12.97	0.74	0.74	1.11	0.74	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	6.97	0.51	0.68	0.00	1.19	0.17	1.70
teratocarcinoma cell line:NCR-G1	10798-110I6	20.50	4.78	2.31	0.31	2.31	0.46	3.24
teratocarcinoma cell line:PA-1	10807-111A6	15.03	1.24	0.77	0.00	0.62	0.46	1.08
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	25.01	4.82	0.76	0.13	0.25	0.63	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	9.83	0.00	0.38	0.00	0.38	0.00	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	27.27	0.87	0.98	0.11	0.33	0.44	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	5.21	0.00	1.63	0.00	0.00	0.00	0.98
testis, adult, pool1	10026-101D8	14.60	0.97	1.83	0.86	1.50	0.00	0.32
testis, adult, pool2	10096-102C6	9.47	0.00	3.61	0.45	3.16	0.00	1.35
thalamus - adult, donor10196	10168-103B6	23.18	1.10	0.00	1.10	2.21	0.00	5.52
thalamus, adult, donor10252	10154-103A1	29.07	1.41	7.35	1.25	6.25	0.47	4.38
thalamus, adult, donor10258, tech_rep1	10370-105G1	13.86	1.54	4.62	1.54	1.54	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	11.20	1.48	3.62	0.16	3.29	0.82	0.49
thalamus, newborn, donor10223	10366-105F6	12.66	0.00	0.00	0.00	2.88	0.00	0.58
throat, adult	10209-103G2	13.98	0.75	5.49	0.50	2.75	0.50	0.00
throat, fetal, donor1	10061-101H7	31.38	3.35	2.74	2.74	2.74	1.22	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	18.08	1.79	0.79	0.00	1.99	0.00	0.60
thymus, adult, pool1	10027-101D9	65.32	3.18	2.19	0.60	1.59	1.99	2.39
thymus, fetal, pool1	10043-101F7	67.43	3.22	5.30	1.45	2.39	1.35	8.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	14.76	0.53	1.20	0.80	0.00	0.13	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	22.49	2.10	1.82	0.70	0.98	0.56	0.70
thyroid, adult, pool1	10028-101E1	26.31	3.17	4.76	2.80	1.59	0.93	0.37
thyroid, fetal, donor1	10060-101H6	24.26	3.95	5.27	1.32	5.01	0.53	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	15.40	0.00	9.24	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	14.19	1.16	1.86	0.70	0.93	0.00	0.47
tongue, fetal, donor1	10059-101H5	19.31	1.18	3.55	1.18	1.58	0.00	0.00
tonsil, adult, pool1	10047-101G2	26.15	1.70	2.30	0.50	0.60	1.00	0.30
trachea, adult, pool1	10029-101E2	20.94	1.64	2.62	1.47	0.82	0.33	0.08
trachea, fetal, donor1	10058-101H4	27.31	1.92	1.92	1.54	3.85	2.31	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	19.13	2.83	0.35	0.71	0.00	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	22.09	0.51	0.20	1.72	0.00	0.61	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	23.82	2.35	1.72	1.10	3.13	0.63	0.31
tridermal teratoma cell line:HGRT	10694-109G1	17.12	3.81	0.00	1.90	1.90	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	18.62	3.22	1.95	2.37	0.85	0.59	0.08
umbilical cord, fetal, donor1	10057-101H3	14.61	6.26	2.09	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	20.30	0.34	4.78	3.41	2.56	0.85	0.68
uterus, fetal, donor1	10055-101H1	32.76	3.07	2.05	0.51	5.63	0.51	3.07
vagina, adult	10204-103F6	19.39	1.29	7.11	4.52	7.11	0.65	1.29
vein, adult	10191-103E2	37.92	1.10	4.38	0.88	1.53	0.44	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	17.36	1.07	0.00	0.27	0.00	1.07	0.53